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p i l a t e d c a r d i o m y o p a t h y ( D C M ) is a c h r o n i c hear t 
muscle disease of unknown etiology characterized by dilatation and 
contracti le dysfunction of left and/or the right ventricle. In man, 
myocarditis is known to be the precursor of DCM in many cases, al-
though clinical and histological diagnoses remain obscure. Since in 
DCM, heart is the only affected organ, it fits into the criteria of organ 
specific autoimmune disease. Autoimmune features in patients with 
DCM include familial aggregation, a weak association with HLA-DR4 
and with immunoglobulin genes, abnormal expression of HLA class II 
on cardiac endothelium and increased levels of circulating cytokines. 
Cardiac antibodies have been found against various antigens in 
DCM patients. Multiplicity of parallel autoimmune reactions directed 
towards a single organ may be due to spread sensitizatio n. Among 
the various cardiac antigens, 150 kD C-protein has been found to in-
duce myocarditis leading to DCM in experimental animals. C-protein 
plays an important role in contractile activity and is one of the major 
constituent proteins which are essential to compete with natural anti-
gens at MHC antigen binding site. 
In the present study, 150 kD human cardiac C-protein was 
electroeluted and further purified by HPLC. C-protein was character-
ized by ultraviolet and circular dichroic spectroscopy andSDS-PAGE. 
Due to identical molecular weights, IgG and C-protein gave a similar 
pattern on 7.5% SDS-PAGE. C-protein is an intracellular member of 
immunoglobulin superfamily and it shares some of its domains with 
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IgG. In order to further substantiate the similarity pattern between 
the two, the above were subjected to urea denaturation. Both IgG and 
C-protein were denatured to give two prominent bands on urea SDS-
PAGf using an acrylamide (5-20%) and a urea (1-lOM) gradient. 
The thermodynamical data speculate the tremendous structural 
stability exhibited by C-protein which is a highly stable dimeric pro-
tein molecule as evident from the observation that only 4.4 percent 
had undergone thermal unfolding till TS^C. Fifty percent denaturation 
was observed at around TQ.S^C. The negative AGj^  values above 79°C sug-
gests the transition of completely folded C-protein to the unfolding 
state. In comparision to native DNA, our results are indicative for C-
protein to be topologically less constrained. The 150 kD C-protein 
which is acting as an autoantigen in DCM was found to be equally 
reactive with naturally occuring SLE autoantibodies in which DNA is 
acting as an autoantigen. The antigenicity of electroeluted HPLC puri-
fied 150 kD cardiac C-protein was assessed by inducing the produc-
tion of polyclonal antibodies in rabbit and rats. The repertoire of 
specificities of induced antibodies was ascertained by direct binding 
and competition ELISA. 
DNA-protein crosslinks have been produced by typical photo-
chemical reactions occuring in biological systems. The crosslinks have 
been found to be covalent in nature and have been responsible for many 
deleterious pathological processes. In this case, the HPLC purified C-
protein was photoadducted to commercially available calf thymus na-
I l l 
tive DNA purified of protein and single stranded regions. Time course 
kinetics revealed that the formation of photoadduct increased with 
increase irradiation time. This was further reiterated by the amount 
of bound lysine residues (from C-protein) to native DNA. Time course 
kinetic study indicates that the formation of photoadduct obeys ap-
parent first order reaction. 
The prima donna in the category of oxygen ^ e e radicals (OFR's) 
are oxygen itself, superoxide, hydrogen peroxide, transition metal ions 
and hydroxyl (OH) radicals, the first four of which interact to gener-
ate the last. These reactive oxygen species also produce DNA-protein 
crosslinks in biological systems. In this study we have induced DNA-
C-protein crosslink by the action of H2O2 and OH. Among the two, 
OH appears to form a better DNA-C-protein adduct in terms of recog-
nition with DCM, SLE and immune sera. The adducts/photoadducts 
were characterized by nuclease SI sensitivity assay. 
Autoantibodies found in DCM patients showed remarkable bind-
ing with HPLC purified C-protein. Competition ELISA results showed 
inhibition in antibody activity ranging from 64.7% to 82.1%. More-
over, inhibition of antibody activity was achieved at a very low mag-
nitude of inhibitor concentration. The induced anti C-protein antibod-
ies exhibited much higher magnitude of binding. These results indi-
cate the major involvement of 150 kD C-protein as an autoantigen in 
DCM. 
Native DNA showed poor reactivity with sera of DCM patients. 
On the contrary, mitochondrial DNA (mt DNA) showed appreciably 
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higher binding with DCM autoant ibodies . On ROS modif ica t ion , the 
magnitude of binding decreased in case of mt DNA whi le it increased 
in case of ds DNA but a relat ively low magni tude of binding was 
observed when nDNA was photoadducted with C-pro te in . Conversely , 
the photoadduct ion of nDNA-C-protein in p resence of OH exhibi ted a 
high degree of b inding. This could be due to cumula t ive binding efect 
of immunogenic epi topes on C-protein as well as somewhat s imilar 
epi topes to the immunogen on ROS modified DNA and hence when 
both ROS-DNA and C-protein were photoadduc ted , a h igher degree of 
binding was observed. This finding suggests that p robab ly apart from 
150kD C-protein, the photoadducted ROS-DNA-C-pro te in complex 
could also act as an al ternate autoantigen for myoca rd i t i s /DCM. 
The binding of induced anti C-protein an t ibod ie s with h is tones , 
ROS his tones , po ly-D- lys ine , poly-L-glutamate and poly (L+G) com-
plex was of low magni tude , thereby, suggest ing for the presence of a 
minor subpopulation of epitopes responding to the anti-C-protein antibod-
ies. Similar binding patterns with DCM autoantibodies further substanti-
ates the finding. 
In the present study, attempts were also made to probe the possible 
involvement of 150kD cardiac C-protein which is an autoant igen in 
myocarditis/DCM, in the induction of autoantibodies in SLE patients. As-
says of anti-DNA and anti-human heart antigens in the sera of DCM and 
SLE patients were carried out by employing direct binding ELISA where as 
specificity determination was accomplished by competition ELISA. Inter-
estingly, as evident from the binding results, human heart extract proteinic 
antigen (s) reactive with DCM autoantibodies showed strong recognition of 
SLE anti-DNA antibodies. This is suggestive for the possible involvement 
of a common or somewhat similar trigger/epitope (s) for immune response 
in autoimmune myocarditis/DCM and autoimmune SLE, although such in-
ferences could not lead to confirmity at such a preliminary level of investi-
gation. The mechanism or the role of myocarditis inducing 150kD C-pro-
tein in stimulation of immune system for production of antibodies in SLE 
remains to be ascertained. 
In conclusion, 150kD human cardiac C-protein has been found to be a 
potent immunogen capable of inducing polyclonal antibodies in experimen-
tal animals. It is a thermodynamically stable molecule and shares some of 
its domains with IgG as revealed by thermal denaturation and urea denatur-
ation studies. C-protein showed strong recognition with DCM sera as well 
as immunoaffinity purified SLE anti-DNA autoantibodies. Out of the ad-
ducts/photoadducts formed by crosslinking C-protein with native DNA, the 
one formed in presence of OH showed strongest recognition towards DCM 
and anti C-protein autoantibodies, thereby indicating the possibility of ROS-
DNA-C-protein photoadduct as an alternate autoantigen in myocarditis/ 
DCM. 
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^ i l a t e d Cardiomyopathy (DCM) is a chronic heart muscle 
disease characterized by impaired systolic function of left or/and right 
ventricle (Richardson et al., 1996). It is a major cause of severe 
congestive heart failure in young people and the commonest cause of 
transplantat ion worldwide. The heart is suscept ible to immune 
mediated injury. The myocytes may be injured during or after immune 
response to endogenous or exogenous cardiac antigens. Immune 
mediated myocyte injury may be reversible and manifested as a 
t rans ien t depression of ven t r i cu la r function and/or e lec t r i ca l 
instability, or it may be irreversible, ultimately leading to myocyte 
necrosis. 
Mechanisms of immune mediated injury may be classified into 
humoral and cellular types. Humoral immunity requires recognition 
of an epitope by antibody molecules expressed by B-lymphocytes and 
depends on circulating antibodies to initiate injury. Several cardiac 
disorders like post myocardial infarction syndrome, idiopathic dilated 
cardiomyopathy, viral myocarditis and doxorubicin cardiotoxicity are 
accompanied by deposition of antibodies within the myocardium, 
particularly on the sarcolemma (Rose et al., 1988). Moreover, 13-95% 
patients with various myocardial diseases such as idiopathic dilated 
cardiomyopathy, myocarditis and hypertrophic cardiomyopathy have 
shown the presence of heart react ive antibodies in their serum 
(Neumann et al., 1990). The major mechanism of cell injury mediated 
by humoral immunity may be the activation of complement via the 
classic pathway. 
Cellular immunity also plays a role in the mechanism underlying 
cardiac dysfunction. It is initiated by recognition of an immunogenic 
epitope by antigen specific T-lymphocytes. This initial recognition 
and activation are effected by helper T-cells and require presence of 
histocompatible antigen presenting cells. Presentation of myocardial 
antigen to T-lymphocytes by antigen presenting cells can result in the 
clonal expansion and differentiation of cytotoxic T-cells, stimulated 
by the release of immune cytokines. As a consequence, myocyte 
necrosis occurs, resulting in fibrosis (Sanderson et al., 1985). 
Extensive studies have provided appreciable evidences for the 
presence of a wide spectrum of autoantibodies against cardiac tissue 
in myocardial diseases (Maisch et al., 1983; Caforio et al., 1992). In 
patients with DCM, circulating autoantibodies to distinct cardiac 
autoantigens have been described providing evidences for autoimmune 
involvement. Thus, autoimmune disorders result due to immunologic 
reactions, humoral and/or cellular, directed against the individuals own 
tissue components. The precise mechanisms underlying the trigger of 
autoimmune reaction are not yet completely understood, however 
certain factors are said to be involved. 
Shoenfeld and Isenberg (1989) described the wide spectrum of 
autoimmune diseases as a mosaic of autoimmunity with many factors 
leading to diverse diseases. 
T-helper/T-suppresser cell imbalance: 
The T-cell sub-sets control / regulate the immune response. In 
autoimmune diseases, the ratio of T-helper (Th) to T-suppresser (Ts) 
cells in peripheral blood tends to be nearly 10-15 : 1, particularly 
during active or acute phase of the disease compared to 2 : 1 in normal 
individuals (Deodhar, 1992). 
Polyclonal B-cell activation: 
Polyclonal B- and/or T-cell activation has been an initiating 
mechanism. The proposition that polyclonal B-cell activators can 
induce autoantibodies is predicted on the existence of non deleted 
self reactive B-cells and/or developmentally arrested anergised B-cells 
that might become active upon appropriate stimulation. A large number 
of molecules, particularly of microbial origin have been found to act 
as polyclonal B-cell activators and in the induction of autoantibodies. 
Polyclonal stimulation of a large set of T-cells by bacterial/viral 
surface antigens (SAgs) is another suggested scenario. T-cells that 
react with MHC class II bound SAg on B-cells may mutually stimulate 
the SAg displaying B-cells, thereby leading to production of polyclonal 
immunoglobulins and in some instances, autoantibodies. Alternatively, 
the activated T-cells themselves may induce tissue damage, through 
cross reactions with self molecules (Theofilopoulos, 1995). 
Genetic factors: 
Gene t i c t ransmiss ion in Id iopa th ic DCM (IDC) has been 
occasionally described in the past while importance of genetic factors 
is a recent advance (Mestroni et al., 1990). In control studies. 
familial IDC is detectable in over 20-25% of patients with a diagnosis 
of I D C , with a prevalent autosomal dominant trait. A single dominant 
locus was proposed and for the putative disease gene, a gene frequency 
in the order of 10"* was estimated in overall population. 
The candidate genes for familial IDC can be divided into two 
main groups, genes that are responsible for normal heart function like 
the ones encoding contractile proteins such as myosin light and heavy 
chain, tropomyosin, troponins and actin. Other candidate genes are 
genes coding for proteins involved in metabolic pathways: genes 
encoding for atrial natriuretic factor and its receptor, phospho lamban, 
G-proteins , p - adrenoceptors and Ca^' channels appear to be of 
particular interest. According to autoimmune pathogenetic hypothesis 
of IDC, the second group of genes are involved in immune function. 
Immune dysfunctions in IDC involves cellular and humoral immunity 
such as organ specif ic au toan t ibod ie s (Caforio et al . , 1994). 
Association studies indicate a strong correlation between disease and 
human leukocyte antigens (HLA). Associat ion between immune 
response (Ir or MHC) and T-cell receptor (TCR) genes and the 
development of immune mediated cardiac injury are not unexpected 
since most autoimmune diseases are T-cell dependent and all T-cell 
mediated responses are major histocompatibili ty complex (MHC) 
restricted (Bach, 1995). MHC may alter predisposition by shaping of 
TCR repertoire, antigenic peptide selection and presentation and 
peptide transport. HLA-DR associations play a major role in patients 
with DCM. HLA-DR positive patients were six times more likely to 
have antibodies compared to those who did npt be long to this 
phenotype. Antibodies against different cellular constituents may have 
distinct immunogenetic associations. On the other hand, HLA-DR4 
and HLA-DRl share common epitopes which may confer susceptibility 
to autoimmunity in DCM. 
In addi t ion , the e x i s t e n c e of an a s s o c i a t i o n b e t w e e n 
autoantibodies, clinically overt disease and certain restriction fragment 
length polymorphisms (RFLPs) of HLA-DRp and -DQa genes suggests 
that subtypes of these molecules may have enhanced pathogenetic 
significance (Limas, 1996). 
Immune deficiency states: 
The availability of severe combined immunodeficient (SCID) 
mouse provides a potentially unique opportunity to study contributions 
made by the immune system in induction of coxsackie virus B3 (CVB3) 
induced myocarditis. Unlike congenitally athymic (nu/nu) mice, the 
SCID mutation results in an absence of both B- and T- cell function, 
due to an aberrant VDJ recombinase mechanism. While no functional 
T- or B-cells are present in the SCID mouse, ant igen presenting 
capabilities and natural killer cell activity are intact (Bosma and 
Caroll, 1991). 
In 1986, Cohen et al. described the first cases of rapidly fatal 
DCM in three AIDS patients. Since then a number of prospective 
clinical and echocardiography studies have shown that a subgroup of 
HIV infected patients may be predisposed to the development of 
clinically significant and progressive heart disease (Herskowitz et al., 
1992; Herskowitz & Baughman, 1994). This subgroup of patients 
frequently present with class HI or IV congestive heart failure and 
demonstrate rapid clinical deterioration. One emerging hypothesis to 
explain the high frequency of dilated heart muscle disease in HIV 
seropositive patients is the association between HIV related ventricular 
dysfunction and myocarditis. The increased CD8+ T-lymphocytes and 
sole induction of MHC class I in the HIV related myocard i t i s 
popula t ion are l ikely due to the marked systemic decrease in 
circulating CD4+ T-lymphocytes in AIDS patients (Levy et al., 1985). 
Studies by Matsumori et al. (1994) have suggested alterations 
in cytokine production in patients with dilated heart muscle disease. 
Patients with HIV related myocarditis have elevated levels of TNF-a 
and IL-6 compared to patients without myocarditis suggesting that 
specific cytokines may play a role in the pathogenesis of HIV related 
myocarditis (Herskowitz et al., 1995). 
Molecular mimicry: 
Most s tudies have addressed molecular mimicry as cross 
reactions of antibodies with linear peptides shared by self and foreign 
molecules (Theofilopoulos, 1995). The term 'molecular mimicry' was 
i n i t i a l l y used in 1968 to exp la in pe r s i s t en t v i ra l i n f ec t i on . 
Autoimmunity provided by molecular mimicry should occur only when 
the microbial and host determinants are similar enough to cross react. 
yet different enough to break immunologic tolerance. The induction 
and breaking of tolerance at both the B- and T-cell levels have been 
established in heterologous serum protein models , and the same 
kinetics probably govern the establishment an4 breaking of tolerance 
to microbial agents cross reacting to host proteins. 
It is to be pointed out that an antibody reacts with the three 
dimensional configuration of a molecule, the antibody could bind but 
with a different affinity, to similar but not necessari ly identical 
configurations. The multiple organ reactive antibodies recognized 
either the same molecule present in more than one organ or different 
molecules in multiple organs (Haspel et al., 1983). Molecular mimicry 
is a common phenomenon. The role cross reacting antibodies play in 
pathogenesis will depend on the nature and location of the autoantigens 
as well as on the properties of the antibodies (Srinivasappa et al., 
1986). Homology by itself may not lead to a cross reacting immune 
r e s p o n s e . Howeve r , unless the homology and subsequen t 
immunological cross reactivity involve a host protein that can 
precipitate disease, the autoimmune response is unlikely to lead to 
autoimmune disease. 
Infectious agents may participate in the induction of autoimmune 
disease not only through the process of mimicry, but also through other 
effects, including tissue damage and release of sequestered antigens, 
availability of cryptic self determinants through increased MHC 
expression, ec topic expression of molecules , redis t r ibut ion of 
intracellular molecules to the cell surface, upregulation or shift in 
the spectrum of cytokine production, immunological exhaustion and 
bystander activation of T-cells (Theofilopoulos, 1995). 
In humans, myocarditis is known to be the precursor of DCM in 
some cases, although clinical and histological diagnosis remains 
obscure (Aretz et al., 1985). The commonest cause of myocarditis is 
said to be a virus infection, but majority of cases are of unknown 
etiology (Woodruff, 1980). Pedigrees where myocarditis and DCM 
were present in different family members have been repor ted 
(O'Connell et al., 1983). 
Since in DCM. the only affected organ is the heart muscle, to 
prove autoimmune involvement, it is necessary that the criteria of an 
organ specific autoimmune disease are fulfilled (Rose and Bona, 1991). 
Autoimmune features in DCM include familial aggregation, a weak 
association with HLA-DR4 and immunoglobulin genes, abnormal 
expression of HLA class II on cardiac endothelium and increased levels 
of circulating cytokines. The organ-specific antibodies produced a 
diffuse cytoplasmic staining of myocytes but did not stain skeletal 
muscle. Antibodies were classified as cross reactive 1, which exhibit 
only partial heart specificity, gave a fine striational staining on cardiac 
tissue and stained weakly skeletal muscle fibres. The entirely cross 
reactive antibodies, classified as cross reactive 2. stained with a broad 
striational pat tern both in heart and skele ta l muscle sec t ions . 
Absorption studies with relevant tissues had confirmed the organ 
specificity and cross reactivity of the antibody types (Caforio et al., 
1990). 
Like other autoimmune conditions, DCM autoantibodies seem 
to be produced against multiple antigen specificities. The multiplicity 
of parallel autoimmune reactions directed towards a single organ could 
be due to spread sensitization. Thus, a single, initial autoantigen would 
give rise to the first attack of the target organ, which would result in 
T-cell mediated inflammation or the release of degradation products. 
These mechanisms would enhance autoantigen presentation or release 
immunogenic cell components that would give rise to a secondary 
autoimmune response that would be difficult to differentiate from the 
primary one. Conversely, as suggested, the initial event is a target 
cell abnormality or lesion that renders a set of immunogenic peptides 
: only the peptide with a sufficient affinity for MHC molecules would 
be recognized by the T-cell repertoire, leading to an autoimmune 
response (Bach, 1995). 
Several autoantigens which react with sera from patients with 
DCM have been identif ied. Studies on t issue from pat ien ts of 
myocardi t i s and DCM have identif ied increased express ion of 
intracellular antigens such as adenine nucleotide translocator (ANT) 
and branched chain ex-ketoacid dehydrogenase (BCKD) complex. 
Antibodies against the intracellular mitochondrial ANT protein cross 
react with myocyte sarcolemmal calcium ion (Ca^ ) channel proteins. 
Binding of Ca' channel proteins by such cross reactive antibodies can 
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thus physiologically alter the metabolism of normal myocyte, possibly 
leading to myocyte injury (Ansari et al., 1991). Since SR-Ca^* ATPase 
constitutes the major calcium regulatory protein in the sarcoplamic 
reticulum regulating myocardial contractility, autoimmune inhibition 
of this enzyme may affect the functional outcome of the myocardium. 
The time dependent association between SR-Ca^^ ATPase immunization 
and development of severity of myocarditic lesions supports the 
immunopathogenetic role of SR-Ca^' ATPase. The involvement of T-
cell immunity may contribute more to the generation of myonecrosis, 
whereas the antibody mediated immunity may contribute more to 
functional impairment and activation of complement (Sharaf et al., 
1994). The ADP/ATP carrier has organ specific antigenic determinants 
although there is a partial identity among the carrier proteins from 
heart, kidney and liver. The organ specificity of ADP/ATP carrier was 
also conf i rmed by the organ specif ic r eac t ion of d i l a t ed 
cardiomyopathy sera with this protein. The autoantibodies reacted with 
antigenic determinants at the cardiac myocyte plasma membrane and 
interacted with atleast one subunit of calcium channel. Therefore, the 
autoantibody was also called the Ca-channel reactive antibody. A cross 
reaction between antigenic determinants could be of pathogenic 
significance because antibodies against the homologies were present 
in pa t i en t s with m y o c a r d i t i s and DCM (Ansar i et a l . , 1 9 8 8 ; 
Schwimmbeck et al., 1993). 
After an au to immune response is in i t i a t ed , c i r c u l a t i n g 
autoantibodies against the ADP/ATP carrier disturb myocardial energy 
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metabolism and cross react with myocyte sarcolemmal Ca^' channel 
proteins. The antibodies were able to bind to the Ca^^ channel and 
enhance calcium influx and calcium overload in cardiac myocytes, 
finally resulting in cytotoxic damage (Liao, 1996). 
The most important intracellular microorganisms associated with 
viral disease include a variety of viruses (Woodruff, 1980), two 
m e m b e r s of ch lamydiae (Chlamydia psittaci and Chlamydia 
pneumoniae) (Kuo et al., 1993), several rickettsiae. Toxoplasma gondi 
and Toxoplasma cruzi (Speirs et al., 1988). Trichinella spiralis is the 
most prone worm to cause myocarditis. Myocarditis pathogenesis may 
be complex and involve various immune mechanisms. In addition, 
many gram-posi t ive and gram-negat ive bacter ia may persis t and 
multiply intracellularly or extracellularly or both and cause damage 
to the myocardium by various pathways . Some bacteria produce 
exotoxins that may cause damage to the myocardium, whereas others 
release endotoxins that may be harmful. The bacteria commonly 
encountered in myocarditis are Beta-hemolytic streptococci (Putterman 
et al., 1991), Corynebacterium diptheriac (Ua\a\daiT, 1992), Neisseria 
meningitidis (Hardman and Earle. , 1969), Yersinia enierocolitica 
(Zollner et al., 1992), Salmonella typhi or paratyphi and Borrelia 
burgdorferi (Klein et al., 1991). Mycoplasma pneumoniae was 
incriminated in 6% of consecutive military conscripts suffering from 
unequivocal myocarditis, and in 1-2% of conscripts hospitalized with 
mycoplasmal infections (Karjalainen, 1990). Trypanosoma cruzi 
(Chagas ' disease) is a well recognized cause of myocarditis and 
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cardiomyopathy in both urban and rural areas of South America. The 
African trypanosomes, T. gambiense and T. rhodesiense occasionally 
cause myocarditis and cardiomyopathy (Tsala Mbala, 1988). 
Coxsackie virion and other viral proteins share epitopes with 
internal or plasma membrane proteins of normal cells (molecular 
mimicry) and s t imulate immune responses which par t ic ipa te in 
autoimmune reactions. These hypotheses may not be exclusive and 
all may be operative in a single model. CVB3 or CVB4 particles share 
epitopes with human cardiac myocyte sarcolemmal proteins, human 
and mouse cardiac myos ins , s t reptococcal M-prote in , adenine-
translocator protein and an unidentified protein(s) on the plasma 
membrane on no rma l mouse ca rd iac myocytes or f ib rob la s t s 
(Srinivasappa et al., 1986). 
This underlines the clearence of virus via rapid and other 
immune responses significantly affects the outcome (acute resolved 
versus acu te / ch ron ic m y o c a r d i t i s ) . Antecedent i n f e c t i o n s by 
heterologous CVB3 serotypes can exacerbate or aneliorate in CVB3 
induced myocarditic challenge mechanism by which shared epitopes 
between viral cel lular prote ins can provide either protect ion or 
increase severity of CVB3 induced myocarditis. Studies by Gauntt et 
al. (1995) suggest that antibodies to only a limited numbers of epitopes 
on the light meromyosin (LMM) rod portion of human cardiac myosin 
(^M) are shared with CVB3m and participated in protection/enhanced 
disease and antibodies to the majority of shared epitopes in LMM are 
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without consequence in CVBSm induced heart disease. Resistance to 
this enterovirus and other intracellular infections partly depends on 
natural kil ler cells (NK) which are vulnerable to the effects of 
environmental pol lutants such as mercury, nickel, 8-tetrachloro-
dibenzo-p-dioxin and methyl mercury. The development of disease as 
seen in the heart of CBS virus infected mice, can be severely affected 
in different ways by different heavy metals . Furthermore, during 
infection, the organ distribution of heavy metals may be changed in a 
specific way for each compound. This may subsequently result in 
altered infectious disease pathogenesis (Ilback et al., 1995). 
The G-protein coupled membrane receptors are all members of 
a superfamily of membrane proteins which structurally share the 
overall bacteriorhodopsin architecture, seven a -helices, spanning 
the membrane lipid bilayer and forming a hydrophobic pocket that 
can serve as a pharmacophore. The seven helices are linked together 
by three extracellular and three intracellular loops. The N-terminus 
of the polypeptide is located in the extracellular space while the C-
terminus is located in the intracellular space. In order to induce an 
immune r e s p o n s e aga ins t G-pro te in c o u p l e d r ecep to r s , two 
requirements are necessary : firstly the receptor must be degraded by 
proteolysis to small fragments and the fragments generated must be 
able to form a complex with one of the MHC or HLA class II molecules 
of the host. 
The functionally important G-protein coupled receptors are (3 -
adrenoceptor and the M2 muscarinic receptor . Anti-p receptor 
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antibodies were present in 30-40% patients of dilated cardiomyopathy. 
These antibodies were produced against P, peptide corresponding to 
the second extracellular loop with little reactivity towards a P^ peptide 
in patients with DCM. P,-adrenergic receptor has two antigenic 
regions. Some of the sera recognize the first extracellular loop, other 
sera the second extracellular loop of the P,-adrenoceptor. The 
dominant epitope in the second loop is the cysteine-containing amino 
acid sequence A-R-R-C-Y-N-D which forms a disulphide bridge with 
the cysteine of first extracellular loop (Wallukat et al., 1995). The 
immunoglobulin fraction isolated from serum samples of myocarditic 
and cardiomyopathic patients contains stimulatory autoantibodies, 
directed against P,-adrenoceptor which increase dose dependently, 
the beating rate of the cultured neonatal heart myocytes. Recent 
studies have pointed out the presence of anti-receptor autoantibodies 
in DCM (Fu et al., 1994). Immunization of genetically predisposed 
mice with cardiac myosin causes cardiac enlargement, the production 
of heart-specific antibodies and a heart condition that resembles 
human DCM. the autoantibodies in patients against human ventricular 
myosin are directed against myosin heavy chain. The a - and P-myosin 
heavy chains are relevant autoantigens by the heart specific antibodies 
detected by immunofluorescence in DCM. In humans, the a -myosin 
heavy chain isoform is expressed exclusively in atrial myocytes, 
whereas the P -isoform is present both in ventricular myocytes and 
slow skeletal muscle fibers (Caforio et al., 1992). Cardiac myosin 
induced myocarditis is T-cell mediated and class II MHC restricted. 
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Myosin-reactive T-cells from normal myosin immunized donors 
induced severe myocarditis in severe combined immunodeficiency 
(SCID) mice. Potential myosin reactive T-cells, though lacking CD4 
or CDS, still remain functional and hence CD4 or CDS molecules are 
not essential for induction of autoimmune myocarditis (Pummerer et 
al., 1995). 
Myosin is an intracellular molecule. Viral infection or other 
causes of tissue necrosis might lead to release or exposure of myosin 
and trigger autoimmunity in individuals with a predisposing genetic 
background. Virus may promote auto-sensi t izat ion to myosin by 
molecular mimicry (Oldstone, 19S7; Srinivasappa, 19S6). Monoclonal 
antibody to coxsackie VP-1 capsid protein has been demonstrated 
which reacts with cardiac myosin heavy chain. 
The mechanism by which myosin as well as other autoantigens 
previously identified may trigger and perpetuate, although not directly 
cause autoimmune disease is unknown. It also remains to be established 
whether the antibodies found in DCM sera have a direct pathogenic 
role or, like the anti-myosin antibodies found in murine autoimmune 
myocarditis, are only markers of immune damage. 
Role of 150 kD cardiac C-protein: 
Cardiac C-protein is found to be a dominant antigen among many 
types of cardiac pro te ins and is known to induce autoimmune 
myocarditis as judged on the basis of experimental studies indicating 
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production of autoantibody by mouse specifically against 150 kD C-
protein on induction of myocarditis. This specific antibody is produced 
inspite of immunization with whole cardiac tissue homogenate . 
Purified C-protein also produced myocarditis and recombinant cardiac 
C-protein (amino acid res idue 205-916) effect ively p roduced 
myocarditis in some mice strains including SMA, DBA/IJ, SJL, and 
02°/A, but not in A/J, AKR/J, or DBA/2J mice strains (Kasahara et 
al., 1994). C-protein is a component of thick filament of skeletal and 
cardiac muscles (Yamamoto and Moos, 1983). The function of C-
protein remains unknown, but it has been suggested that C-protein 
may regulate thick filament assembly and length (Squire, 1981), 
participate in thick filament structural support (Pepe et al., 1975), 
maintain the structure and contribute to the radial elasticity of the 
sarcomere, or regulate cross-bridge movement during contraction 
(Magid et al., 1984). 
C-protein has a number of properties that make particularly 
attractive the suggestion that it plays a role in regulation of contractile 
activity. For example, C-protein binds to both purified actin (Moos et 
al., 1978) and myosin (Moos et al., 1975) and can alter the ability of 
actin to stimulate myosin ATPase (Moos and Feng, 1980). The effects 
of C-protein on ATPase activity are, however, complex . C-protein 
inhibits skeletal muscle actomyosin ATPase, but stimulate cardiac 
muscle actomyosin ATPase (Yamamoto and Moos, 1983). It has been 
suggested that the physiological role of C-protein may involve a 
calcium-regulated binding of C-protein to thin filaments, because C-
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protein binding to native thin filaments occurs only in the presence 
of micromolar concentrations of calcium (Moos, 1981). It has been 
shown that C-protein in cardiac muscle becomes phosphorylated in 
response to P-adrenergic agonists and dephosphorylated in response 
to cholinergic agonists (Hartzell and Titus, 1982). The level of protein 
phosphorylation correlates with the rate of relaxation of cardiac 
contraction and it has been suggested that C-protein regulates twitch 
relaxation in cardiac muscle. Electron microscopy shows C-protein 
to be V-shaped. The other par t ic les could be seen as distorted, 
stretched or collapsed V-shaped particles. 
C-protein is one of the major constituent protein necessary to 
compete with natural antigens such as invariant chain and MHC to 
obtain the position at the MHC-antigen binding site (Demotz et al., 
1990; Harding and Unanue , 1990). Moreover, C-prote in is an 
intracellular member of the immunoglobulin superfamily (Einheber 
and Fischman, 1990). IgG like domains are conserved in most cell 
surface immune recognition molecules and also TCR and MHC class 
II have this domain (Williams and Barclay, 1988). The peptides of 
recycled membrane proteins, class II HLA and invariant chain, have 
been shown to be major self-antigens which are presented by class II 
molecules. However, the HLA binding motifs are located in the 
variable domain of this structure, not in this constant IgG like domain 
(Rudensky et al., 1992; Baum et al., 1993). The question remains 
whether or not these IgG like conformations work with each other at 
cell surface similar to the directly bound MHC-TCR like superantigen 
(Woodland and Blackman, 1993). 
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The findings of Kasahara et al. (1994) conflict with an earlier 
report that myosin is the major antigen producing au to immune 
myocarditis under H-2 genetic restriction (Neu et al., 1987). In SMA 
mice, repeated injections of myosin-enriched heart extract with K 0 3 
LPS still preferentially produced the autoantibody to C-protein. In 
addition, myosin contamination was completely avoided by using the 
fusion protein expressed in E. coli PI6-4, which is encoded by part of 
the cDNA of C-protein. CB3 induced myocarditis which might further 
trigger autoimmune reactions against myosin by a molecular mimicry 
mechan ism, has been sugges ted to be a p o s s i b l e u n d e r l y i n g 
pathogenesis in DCM (Noel et al., 1991). Kasahara et al. (1994) 
suggested that the autoimmune triggering mechanism in C-protein 
induced myocarditis may differ from a CB3-triggered or myosin-
triggered mechanism because cross-reactive epitopes between CBS and 
C-protein have not been reported; contrary to the previous results that 
A/J, C3H/He, Balb/c, DBA/2 strains have a high susceptibility to CB3 
(Lawrence et al., 1991), the C-protein residue 205-916 hardly induced 
myocarditis in these strains. 
Fur ther assessment about the i nvo lvemen t of C-pro te in 
t r iggered autoimmune myocardi t i s in DCM, immunoblot t ing was 
employed with sera of 16 DCM patients against whole cardiac 
proteins. Out of 16 DCM patients sera of 2 patients preferentially 
recognized the C-proiein. On the contrary, none of the control sera 
reacted specifically to C-protein (Kasahara et al., 1994). 
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crossreactivity. The maximum score possible for each peptide is 
variable and is determined by its length and by the amino acids present, 
rarer amino acids having a higher value. The scoring system used, 
attaches the highest values to exact matching of rare amino acids. This 
level of matching would be expected to lead to cross reactivity of 
epitopes since far weaker matching occurs within conserved motifs of 
peptide^ bound to class II major histocompatibility complex peptides. 
Differences between individuals in MHC class II may influence the 
selection of particular hsp epitope and the corresponding target antigen 
that gives rise to an autoimmune disease (Jones et al., 1991). 
The amino acid sequences/peptides of autoantigen region 384-
396 and 451-470 of hsp share homology with the amino acid sequences/ 
peptides of myosin heavy chain 136-148 and 253-272 with a similarity 
score of 65 and 64, respectively, as seen in coxsackie myocarditis 
(Jones et al., 1991). Latif et al. (1993) have reported antibodies against 
a 60 kD band in 85% DCM patients by Western blotting. Two 
dimensional gel analysis and protein sequencing revealed 100% 
homology of this peptide with hsp 60. The presence of circulating 
antibodies against hsp 60 in 85% of DCM patients is clear evidence 
of a damaged myocardium. This suggests that myocyte injury induces 
the expression of hsp60 or other stress proteins that may have immuno-
modulatory activities and could influence the development and course 
of autoimmune recognition of the myocardium. The exact pattern and 
distribution of hsp60 in normal and diseased myocardium remains to 
be established. 
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DNA-protein photoadducts/photointeractions: 
A variety of chemicals and ionizing and ul traviolet (UV) 
radiations are known to produce DNA-protein crosslinks (Oleinick et 
al., 1986). Several reports indicate that the bonds formed between DNA 
and proteins are of covalent nature (Oleinick et al., 1986; Cress and 
Bowden, 1983). Proteins and nucleic acids are the two most important 
classes of functional biomolecules in cel ls . These "co lour less" 
macromolecules absorb in the UV region of spectrum. Typical 
photochemical reactions have been identified that are relevant to 
biological damage induced by exposure of organisms to radiation. 
The crosslinking of nucleic acids to protein is one of the lesions 
produced in biological systems by UV light, which has been observed 
in bacteria (Smith, 1962; Alexander and Moroson, 1962; Bridges et 
al., 1967) and in mammalian cells (Alexander and Moroson, 1962; 
Habazin and Han, 1970; Han et al., 1975; Zimmernan et al., 1972). 
The photobinding of serum albumin to DNA (Maukovitz, 1972) and 
gene-5-protein to bacteriophage IdDNA (Anderson et al., 1975) 
provides direct proof at a molecular level for the crossl inking 
p h e n o m e n o n . The role of DNA-pro t e in c ros s l inks in ag ing , 
carcinogenesis and radiation biology has been well documented 
(Smith, 1975). 
The recognit ion between nucleic acids and proteins is of 
fundamental importance since it triggers most steps of nucleic acid 
metabolism. This recognition, presumably, first involves electrostatic 
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interactions of phosphate groups with positively charged regions in 
proteins; then, more specific interactions take place which involve 
possible interactions between nucleic acids bases (or other structural 
elements) and amino acids side chains in proteins. A more extended 
scope of examination reveals the possible recognition of secondary 
or tertiary structures of nucleic acids by proteins. In either cases, 
recognition may be dependent of nucleotide sequence (Duguet, 1981). 
The initial isolation of a mixed photoproduct of thymine and 
cysteine (5-S-cysteine-6-hydrothymine) from in vitro UV irradiation 
of a solution of thymine and cysteine has served as a model for 
crosslinking phenomenon. Fifteen amino acids have been found to 
react photochemically with DNA. Cysteine, lysine, phenylalanine, 
tryptophan and tyrosine were the most reactive; alanine, aspartic acid, 
glutamic acid, serine and threonine are unreactive (Shetlar et al., 
1985). It has been suggested that the resistance of Micrococcus 
radiodurans, one of the most radiation resistant organisms known, is 
due to its extraordinary ability to repair pyrimidine dimers, but what 
ultimately kills the organism is damage that involves both DNA and 
protein. The crosslinking of DNA and protein may constitute one type 
of such damage (Shetlar, 1980). 
A different type of photochemisty arises when protein and DNA 
are irradiated together as compared to when they are irradiated 
separately. Since, DNA and proteins do not exist in cells as pure 
solutions of the separate molecules but are in intimate contact with 
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each other, it is suggested that photochemical interaction of DNA and 
protein would play a significant role in the inactivation of UV 
irradiated cells under certain conditions. 
Hydroxyl (OH) radicals produced from water by ionizing 
radiation appeared to be responsible for the formation of ionizing 
radiation induced DNA-protein crosslinks iil isolated chromatin and 
in intact cells (Oleinick et al., 1986; Mee and Adelstein, 1981). The 
nucleosomal core of the histones as well as non-histone proteins has 
been found to be involved in the formation of DNA-protein crosslinks 
in isolated chromatin exposed to ionizing radiation (Mee and 
Adelstein, 1981). The hydroxyl radical induced formation of DNA-
protein crosslink between methyl group of a Thy moiety and the C-3 
position of a Tyr moiety in calf thymus nucleohistone in aqueous 
solution has been described (Dizdaroglu et al., 1989). 
DNA-protein crosslinking in normal and solar UV sensitive ICR 
2A frog cell lines exposed to solar UV radiation has been observed 
(Rosenstein et al., 1989). Induction of DNA-protein crosslinks in these 
mutant cell lines may help in examining the role played by this type 
of DNA damage in the hypersensitivity to solar UV radiation which 
are exhibited by these mutant cells. These crosslinks might be lethal 
to the cell if they interfere with normal gene functions. 
Role of free radicals: 
A free radical can be defined as a chemical species possessing 
an unpaired electron and is capable of independent existence. Free 
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radicals can be formed by: 
i) Hemolytic cleavage of a covalent bond of a normal 
molecule, with each fragment containing one of the 
unpaired electrons 
ii) By the loss of a single electron from a normal molecule 
iii) By the addition of a single electron to a normal 
molecule. 
The prima donna in the biochemistry of oxygen free radicals 
are oxygen itself, superoxide, hydrogen peroxide, transition metal ions 
and the hydroxyl radical, the first four of which conspire by a variety 
of interactions to generate the last (Halliwell and Gutteridge, 1990). 
Under normal circumstances, the major source of free radicals in cells 
is electron 'leakage' from electron transport chains. These can be 
mediated by the action of enzymes or non-enzymatically, often through 
the red-ox chemistry of transition metal ions (Cheeseman and Slater, 
1993). Free radical production can also be increased by exogenous 
sources like toxic foreign compounds and ionizing radiations. 
Although there are several sites of ROS generation in cells, the main 
source of O^'and its stoichiometric product, H^O^ is the auto oxidation 
of the reduced components of the mitochondrial electron transport 
chain (Haiku et al, 1993). In the presence of trace amounts of transition 
metal (M) ions (i.e. Fe^^ Cu" '^) found in biological systems (Halliwell 
and Gutteridge, 1985), H^O^ can participate readily in Fenton-like 
reactions (Fenton, 1894; Cohen, 1985) resulting in the production of 
OH as shown. 
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Mn+ + H ^ O ^ ^ M(" ')+ OH + OH 
Hydroxyl radicals have been implicated in the dele ter ious 
processes such as gene mutation (Okada, 1970), cell transformation 
(Borek, 1985) and cell death (Painter, 1980). Nitric oxide (NO') is an 
important physiological free radical produced by phagocytes in which 
the unpaired electron is delocalized between two atoms. Nitric oxide 
or its derivative acts upon smooth muscle cells in vessel walls to 
produce relaxation, besides acting as a neurotransmitter (Hirono et 
al., 1997). 
DNA damage by ROS: 
DNA is an important target for free radicals since it is clearly 
of major significance for cell function as well as its susceptibility of 
being damaged by oxidizing radicals (Wiseman and Halliwell, 1996). 
The most important reac t ions seems to be based on hydrogen 
abstraction to form carbon-centered radicals followed by oxygen 
addition to form peroxyl radicals that subsequently decay. Addition 
of OH to double bonds is also an important mechanism. Both the 
nucleobases and the sugar phosphates offer potent ia l targets for 
hydroxyl radicals (*0H). The consequences of oxidat ive radical 
damage to DNA are highly serious which inc ludes cell death, 
reproductive cell death, mutation and transformation into cancer cells 
(Feig et al., 1994). Oxidative damage to DNA includes a range of 
specifically oxidized purines and pyrimidines as well as alkali labile 
sites and strand breaks formed directly or by repair processes 
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.(Dizdaroglu, 1991; Dizdaroglu, 1994; Breen, 1995). The apparently 
most abundant and certainly the most studied oxidative modification 
of DNA bases involves the C-8 hydroxylation of guanine, frequently 
est imated as the oxidized deoxynucleos ide , 8-oxo-7,8-dihydro-
2'deoxyguanosine (8-oxodG). Oxidation of guanine can also lead to 
the ring opened product of 2,6-diamino-4-hydroxy-5-formamido 
pyrimidine (Dizdaroglu, 1991). Other abundant oxidatively modified 
purines and pyrimidines include 8-oxoadenine, 2-hydroxyadenine, 
Fapy adenine, 5-hydroxy methyluracil, 5-hydroxycytosine, cytosine 
glycol and thymine glycol (Tg). In addition, a large number of other 
modifications of bases and sugars have been identified (Dizdaroglu, 
1991; Dizdaroglu, 1994). All these modifications are present in DNA, 
and the level can be increased in vivo or in vitro by systems generating 
ROS. The yie ld of the individual DNA modificat ions is highly 
dependent on which ROS are involved. Thus, whereas, singlet oxygen 
induces preferentially 8-oxodG (Epe, 1991), superoxide has low 
reactivity to induce this modification at all. Apriori to the above, 
hydroxyl radicals can cause almost any modification (Dizdaroglu, 
1991). In addition, the target molecule conditions, such as oxygen 
tension, chelation of transition metals and the presence of reductants 
may influence the yield and nature of oxidative DNA modifications 
(Dizdaroglu, 1994). 
Oxidative modifications of DNA bases can lead to mutations if 
left unpaired or repaired with errors before replication. From studies 
on bacteriophage and plasmid DNA, it appears that although radicals 
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generated by iojiizing radiations damage all four bases, mutations are 
usually related to modifications of GC base pairs in contrast to AT 
base pairs. Thus, AT base pair perturbations/modifications rarely lead 
to mutations . The mutations are clustered in hotspots and are mainly 
base pair substitutions, whereas, base deletions, large deletions, and 
insertions are less frequent. Hydroxyl radicals generated from ionizing 
radiation induce mainly GC to CG or AT base pair substi tutions, 
depending on DNA expression system, whereas, hydrogen radicals 
preferentially induce GC to AT substitutions (Retil et al., 1993). 
Singlet oxygen and 1,2-dioxetanes preferentially induce 8-oxodG and 
GC to AT base pair substitutions (Epe, 1991; Retel et al., 1993; Emmert 
et al., 1995). In agreement, modified guanine such as 8-oxoguanine 
and apurinic sites are mispaired mainly with adenine, at a frequency 
dependent on the adjacent base sequences and the involved polymerase 
(Kamiya et al., 1995). Majority of ROS induced mutations appear to 
involve modification of guanine, in particular 8-oxoguanine, causing 
G to T transversions. In addition to the mutations related to mispairing 
to oxidised bases, ROS may also cause reduced fidelity of DNA J3 
polymerase (Feig and Loeb, 1993) and alter the methylation of 
cytosine and thus gene control (Weitzman et al., 1994; Loft and 
Poulsen, 1996). 
Protein damage by ROS: 
Most proteins are susceptible to modification by OH or by OH 
+ O "^ (+ Oj). The modification includes altered molecular weight 
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(aggregation or fragmentation), altered net electrical charge (+ or - ) , 
loss of tryptophan, and production of bityrosine. Since Oj 'alone has 
no measurable effect on any of these parameters, it has been suggested 
that OH is the initiating species. Oxygen and/or O2" appear to modify 
significantly the damage induced by OH. Protein fragmentation has 
been reported following exposure to OH + O^-*- Oj (Garrison et al., 
1962; Schuessler and Schilling, 1984). This process involves hydrogen 
abstraction by OH from amino acid a-carbon atoms, followed by 
reaction with O^to produce peroxyl species. Decomposition of carbon 
peroxides was proposed as the mechanism for protein fragmentation 
(Garrison et al., 1962). 
All amino acids in the protein are susceptible to modification 
by OH or by OH + 0 , ( + O^). In contrast, O^"alone appeared only to 
reduce cysteine residues. In agreement with known rate constants for 
reaction of free amino acids with H, tryptophan, histidine and cysteine 
are more vulnerable than most other residues. Tyrosine is formed as a 
simple addition product of OH + phenylalanine. The selectivity of 
OH for tryptophan, tyrosine, histidine and cysteine is less than might 
expected from reactions with free amino acids (Dorfman and Adams, 
1973). The p rocess of aggregat ion by OH appears to involve 
intermolecular bityrosine formation. It is highly unlikely, however, 
that bityrosine is the only (non-disulfide) covalent modification. 
Essentially any amino acid radical formed within a peptide chain could 
crosslink with an amino acid radical in another protein. Alternatively, 
some radicals may crosslink with amino acid molecules. Protein 
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denaturation also preceded increases in proteolytic suscept ibi l i ty 
following exposure to OH + O^. Thus d e n a t u r a t i o n / i n c r e a s e d 
hydrophobic i ty is a pos s ib l e cause for enhanced p r o t e o l y s i s . 
Oxidatively denatured proteins are degraded by novel ATP and calcium 
independent, soluble proteolytic systems (Davies et al., 1987). 
ROS in SLE: 
Antibodies to DNA in SLE have been extensively studied and 
may be specific for ssDNA, reactive with both ssDNA and dsDNA or 
specific for dsDNA (Worrall et al., 1990; Stollar, 1979). However, it 
is ant ibodies to nat ive dsDNA that r epresen t a c h a r a c t e r i s t i c 
serological finding in these patients and are of important diagnostic 
and clinical value. It has been shown that modification of DNA can 
render it more immunogenic (Ali et al., 1985). Native dsDNA has been 
reported to be a weak immunogen (Tan and Stoughton, 1969) and yet 
in certain autoimmune conditions like SLE, autoantibodies to multiple 
nuclear antigens, including DNA and histones are formed. Blount et 
al, (1991) postulated that DNA damaged by ROS may affect the 
development of autoimmune diseases, like SLE. The process by which 
DNA is damaged in such cases may involve the release of ROS 
inteiinediates during the characteristic respiratory burst of activated 
neutrophils, denature DNA in such a way that SLE serum anti-DNA 
antibodies bind better to it (Blount et al., 1989). ROS denaturation 
exposes base residues in the DNA backbone and minor regions of 
ssDNA. Lymphocytes i so la ted from pat ien ts with SLE contain 
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increased levels of 8-oxodG in the DNA. In urine, the SLE patients 
did not secrete 8-oxodG. A study on cultivated blood monocytes 
isolated from SLE patients showed reduced capacity for repair of 8-
oxodG induced by incubation with hydrogen peroxide. In DNA isolated 
from immune complexes precipitated from plasma, 8-oxodg was a 100 
fold more abundant in SLE patients compared to usual values of 
nuclear DNA. This oxidatively modified DNA may be a source of DNA 
antibodies characteristic for SLE. The SLE patients suffer from an 
increased rate of oxidative DNA damage and also from deficient repair. 
This may contribute to the pathogenesis and even to increased risk of 
malignant diseases in these patients (Lunec et al., 1994; Bashir et al., 
1993). Hydroxyl free-radical mediated in vitro modification of calf 
thymus DNA showed single strand breaks, decrease in melt ing 
temperature and structural alteration of purine and pyrimidine bases 
leading to polyspecificity of induced antibodies (Alam et al., 1993, 
Ara and Ali, 1993). Antibodies against free radical modified DNA 
recognize B-conformation (Ara et al., 1992). ROS modified DNA 
promises to be a more discriminating antigen than native DNA for 
binding of SLE autoantibodies (Ara and Ali, 1993) and the binding 
increased considerably with increase in DNA fragment size (Ara and 
Ali, 1992). 
ROS/RNS in autoimmune myocarditis/DCM: 
Oxygen derived free radicals and their metabolites have been 
implicated to participate in various types of myocardial injury. These 
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radicals and metabolites are thought to mainly consist of superoxide 
anion (O^'" ) hydrogen peroxide (H^O^) and hydroxyl radical (OH), 
however, the culprit playing the most important role is still 
undetermined. The involvement of HjO^ generated through dismutation 
of 02'caused severe myocardial damage (Kloner et al., 1989). Oxygen 
derived free radicals and their metabolites can cause enzyme 
inactivation either directly or indirectly (Miki et al., 1988). Thus, 
functional deterioration may be linked to ATP reduction by inactivation 
of enzymes necessary for glycosylation and oxidative phosphorylation 
(Goldhaker et al., 1989). On the other hand, calcium transport in the 
sarcoplasmic reticulum has been demonstrated to be decreased by 
exposure to oxygen radicals (Hess et al., 1984). *0H, on the other 
hand, is produced by H^Oj through iron catalysed Haber Weiss reaction 
(Haber and Weiss, 1934) and is highly reactive. It causes lipid 
peroxidation of the biological membranes (Meerson et al., 1982) 
resulting in changes in membrane permeability and fluidity, and finally 
results in loss of membrane integrity. The plasma membrane and 
mitochondria are more damaged in the heart exposed to higher OH 
levels. The combination of these changes may have resulted in 
decreased contractility in hearts exposed to OH (Takemura et al., 
1994). Experimental studies by Fukuchi et al. (1991) have indicated 
the possible involvement of free radicals and antioxidants in the early 
stages of the development of cardiomyopathy in BIO 14.6 Syrian 
hamster. 
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Recent studies on the molecular genetics of the myocardium have 
revealed that a certain percentage of patients with DCM possess 
mutation in the mitochondrial (mt) DNA of the myocardium. These 
patients can be regarded as microchondrial cardiomyopathy (mtCM), 
a new clinical entity. The cumulative increase in oxygen free radical 
damage in human heart mt DNA closely correlates with deletions 
associated with age and with mtCM. This led us to the ' redox 
mechanism of ageing and degenerative disease ' in which the oxygen 
free radical damage in mt DNA results in a cumulative increase in 
somatic mutations, leading to bioenergetic deficit, cell death, ageing 
and degenerative diseases. The accumulation of hydroxyl radical 
adducts in mt DNA hydrolysate, such as 8-hydroxydeoxyguanosine 
(8-OH-dG) in place of deoxyguanosine (dG), could satisfy this 
prerequisite to the deletion (Hayakawa et al., 1992). The mt DNA, 
having no protective protein, is located inside the inner mt membrane. 
During the evolution from yeast to mammals, mt DNA reduced to one 
fifth of its size by loss of introns. Thus, human mt DNA more easily 
acquires oxygen free radical damage than single celled organisms. The 
revelation that human mt DNA is highly susceptible to hydroxyl attack 
resulting in breakdown into hundreds of mini circles suggests that the 
major target of the active cell death machinery would be mt DNA. 
The cumulative and synergistic increase in oxygen damage and 
deletions in mt DNA associated with age implies that normal ageing 
and development seem to be the two sides of a coin. The cell death 
machinery could be easily imbalanced by the point mutat ions. 
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especially (syn) , in the mt DNA of patients with mtCM, leading to 
their premature ageing (Ozawa, 1995). 
In recent years, nitric oxide (NO) has been implicated in a wide 
variety of immunologically mediated disorders. Pathologic release of 
NO is considered to be one of the probable cause of diminished 
myocardial contractility such as septic shock (Brady et al., 1992), 
cardiac allograft rejection (Yang et al., 1994) and some form of 
idiopathic dilated cardiomyopathy (Winlaw et al., 1994). Human 
myocarditis varies greatly in origin and is generally a self limiting 
process; acute congestive heart failure may develop during the active 
phase, but cardiac function improves significantly in most cases as 
myocarditis resolves histologically (Mason et al., 1995). It is possible 
that the excessive production of NO by inducible nitric oxide synthase 
(iNOS) is responsible for the development of myocardial organic 
lesions as well as for functional changes in myocardial contractility 
during the active phase of the disease. 
Physiological actions of NO are mediated through the activation 
of soluble guanyla te cyclase and the c o n s e q u e n t e levat ion of 
intracellular cGMP level (Moncada and Higg, 1993). Studies suggest 
that NO modulates myocardial contractility through an increase in 
myocardial cGMP. It is reported that cGMP produces inhibition of 
Ca^* influx into myocytes (Levi et al., 1989) or attenuation of the 
positive inotropic effect of p-adrenergic stimulation (Watanabe and 
Besch Jr., 1975). It is also possible that excessive and prolonged 
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production of NO by iNOS in infiltrating inflammatory cells modulates 
the mitochondrial respiration in surrounding viable myocytes, thus 
NO synthase inhibition in the early phase of viral myocarditis may 
alter the adequate immune response to invading cardiotropic virus, 
thus preventing the elimination of virus from cardiac tissue (Hirono 
et al., 1997). 
Systemic lupus erythematosus: 
Systemic lupus erythematosus (SLE) is a multisystem prototype 
auto immune disease (Isenberg and Shoenfeld , 1987) which is 
characterized by the appearance of circulating of autoantibodies that 
bind to numerous cellular and macromolecular antigens of self and 
exogenous origin. Although there is a distinct correlation between SLE 
and immune system, SLE continues to remain as a disease of unknown 
etiology and origin. It has been postulated that immune responses 
against host antigens could resul t from genetic p red ispos i t ion , 
exaggerated B-cell activity, cross reactivity between foreign and host 
antigens or modification of host antigen as a consequence of infection, 
inflammation, drug administration etc. 
A lot of literature is available on the production and assay of 
antibodies to DNA, structural analysis of specific antibody-nucleic 
acid interaction and their application in biomedical research (Stollar, 
1992). A central paradox of the pathogenesis of SLE is the origin of 
anti-DNA antibodies. DNA to which most of the antibodies are 
detected in SLE and other autoimmune disorders, is no longer regarded 
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as the inciting antigen because immunization with native DNA does 
not induce SLE like disease. Animals immunized with covalently/non 
covalently modified DNA induced high titre antibodies, which are 
almost exclusively directed towards modified structures (Stollar, 
1989). Genes encoding anti-DNA antibodies, however, are not 
restricted to SLE and are part of normal B-cell repertoire (Cairns et 
al., 1989; Stewart et al., 1993). The possible role of immunogenic 
DNA, DNA-psoralen crosslink, hydroxyl radical, positively charged 
amino acids and P-estradiol in the pathogenesis of SLE has also been 
reported (Pisetsky et al., 1990; Hasan et al., 1991; Moinuddin and 
Ali, 1994; Alam et al., 1993; Ara and Ali, 1993; Ara and Ali, 1992; 
Alam et al., 1992; Ara et al., 1992). 
Anti-DNA antibodies have been shown to cross react with 
polynucleotides (Lafer et al., 1981), polynegatively charged structures 
such as phospholipids (Smeenk et al., 1987), proteoglycans (Faaber 
et al., 1986), cardiolipin (Eilat et al., 1986), dextran sulphate (Wollina, 
1985), membrane associated proteins (Jacob et al., 1984), intermediate 
filament of cytoskeleton (Andre - Schwartz et al., 1984), histones 
(Gohill and Fritzler, 1987), bacterial products (Carroll et al., 1985), 
platelets (Zouali et al., 1988), hyaluronic acid and chondroitin sulphate 
(Faaber et al., 1984). Monoclonal anti-DNA antibodies of both human 
and murine origin showed cross reactivity with antigens other than 
DNA (Shoenfeld et al., 1983). There are many compounds in the 
vicinity of DNA which may react upon irradiation. These compounds 
include polyamines, histones and nuclear matrix elements. Polybasic 
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molecules found in cells have great affinity for acidic-constituents 
such as DNA (Held and Awad, 1991) and their interaction may play a 
role in the pathogenes is of SLE. Thus , the po lyspec i f i c i ty of 
monoclonal anti-DNA antibodies and synthetic polypeptide antigens 
suggests that antigens other than normal self ant igens serve as 
immunogenic triggers. 
SLE is a non organ specific autoimmune disease and as seen 
earlier, a large panoply of autoantibodies have been identified in the 
serum of lupus patients in varying frequency. The clinical picture of 
SLE shows malar and discoid rashes, photosensitivity, oral ulcers, non-
eros ive a r t h r i t i s , p l e u r i t i s , p e r i c a r d i t i s , h e m o l y t i c anaemia , 
lymphopenia and thrombocytopenia. 
Anti-DNA antibodies play a major role in the development of 
lupus nephritis in MRL/lpr mice. Although anti - dsDNA antibodies 
are considered to be the hallmarks of human lupus nephritis, most of 
the anti-DNA antibodies in the murine lesions also bind to ssDNA 
(Gavalchin et al., 1987). Before the onset of disease, the production 
of anti-DNA antibodies shifts markedly from IgM to IgG isotype 
(Papoian et al., 1974). This sw^itch is also associated with an increased 
cationic charge of the anti-DNA antibody production (Batta et al., 
1987). The majority of anti - DNA antibodies in the renal lesions are 
of lgG2a and IgG2b subclasses (Gavalchin et al., 1987). 
Purified forms of nucleic acids are poor immunogens (StoUar, 
1973). Modification of DNA, for example by ultraviolet light exposure 
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(Davis et al., 1976) or the presentation to the immune system of DNA 
fragments (Lafer et al., 1981) has induced antibodies which bind to 
immunogen but not to unmodified B-DNA. 
The anti-DNA antibody response of lupus mice resembles an 
antigen driven response that is composed of antibodies that are 
heterogeneous in their DNA binding specificity. More compelling 
evidence for the role of DNA as a selecting antigen has been obtained 
from the sequencing of panels of anti-DNA antibodies isolated from 
individual lupus mice (Schlomchik et al., 1990). Since the antibodies 
in these panels all bind to DNA and show clonal restriction, it may be 
concluded that DNA functions in vivo as a selecting antigen. A microbe 
possessing both foreign epitopes and epitopes that mimic autoantigens 
has the potential to elicit an autoimmune response (Rekvig, 1995). 
Nucleic acids complexed with proteins have also been considered as 
potential immunogens. Many human monoclonal anti-DNA antibodies 
of both isotypes use VH genes which are members of fetally expressed 
repertoire. It is possible that these genes contain CDR sequences which 
lend themselves to formation of a DNA binding site. Comparison of 
sequences of large numbers of anti-DNA antibodies enables us to 
identify motifs which might contribute to such binding properties. 
Comparison of the sequence of antibody cDNA with that of the 
germline gene from which it is derived enables us to identify the 
positions and nature of somatic mutations which may likewise 
contribute to antigen binding (Isenberg et al, 1997). 
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Cardiovascular manifestations of SLE: 
The cardiovascular manifestations of SLE have become more 
apparent with prolonged survival and improvement in diagnost ic 
modalities. While most patients still die of infection or renal failure, 
the incidence of cardiovascular morbidity and mortality in SLE is 
rising, and is now the third leading cause of death in SLE (Urowitz et 
al., 1976). Whether there is a cardiomyopathy directly attributable to 
lupus is unresolved. Most series cite a high incidence of heart failure 
but attribute it to multiple problems, including; fever, infections, 
anaemia , u raemia , h y p e r t e n s i o n , s t e ro ids and a c c e l e r a t e d 
atherosclerosis. Studies on systolic time interval in SLE patients 
indicate a shorter left ventricular ejection time and a longer pre-
ejection period than control subjects, suggesting left ventricular 
systolic dysfunction, an indicator for primary lupus cardiomyopathy 
(delRio et al., 1978). Haemodynamic studies have revealed that lupus 
cardiomyopathy may exist even without clinical signs or may represent 
abnormalities of the intrinsic contractile and relaxation properties of 
the myocardium (Strauer et al., 1976). Various etiologies have been 
proposed for lupus cardiomyopathy. Das and Cassidy (1973) detected 
anti heart antibodies in 20 of 32 patients with SLE and proposed that 
these antibodies might be involved in the genesis of myocardial 
dysfunction in lupus. Bidani et al (1980) demonstrated immune 
complexes in the myocardium in 9 of 10 necropsies. They proposed 
that immune complex deposi t ion led to complement act ivation, 
inflammation and myocardial damage. Either mechanism (anti heart 
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antibodies or immune complex deposition) may provoke the small 
vessel vasculitis, focal myocarditis, fibrosis and myocardial necrosis 
that is seen at autopsy in many SLE hearts. Further evidence is needed, 
however, to establish the link between these pathologic findings, 
immunologic abnormalities and cardiac dysfunction in v/vo (Doherty 
and Siegel, 1985). Frustaci et al. (1996) have recently reported a case 
of lupus myoca rd i t i s caus ing left v e n t r i c u l a r a n e u r y s m . An 
immunologic mechanism of myocardial damage in this patient is 
suggested by the results of serologic studies (increased anti-nuclear 
antibodies, increased anti-DNA, decreased C3-4, increased ant i -
sarcolemmal antibodies) by the normal coronary arteriogram and by 
the cardiac biopsy which showed active myocarditis and fibrinous 
e n d o c a r d i t i s . Pos t -mor tem s t u d i e s have r evea led m y o c a r d i a l 
inflammatory lesions in upto 70% of victims of SLE. It remains to be 
seen if improved diagnosis and t reatment of the cardiovascular 
manifestations of SLE can enhance survival. 
Objectives of the present s tudy: 
Organ specific au to immune d isease are charac ter ized by 
production of autoantibodies which react with autoantigens unique to 
that organ. Since in DCM, the only affected organ is the heart muscle, 
it is necessary that the criteria of an organ specific autoimmune disease 
is fulfil led. This includes gene t ic p red i spos i t ion , presence of 
inflammation and abnormal HLA molecule expression in target organ, 
reproduction of human disease in susceptible animals with relevant 
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autoantigens and detection of organ and disease specific antibodies 
in affected patients and symptom free relatives. Although there is 
evidence that autoantibodies of DCM patients react to several different 
proteins, the epitopes for experimental autoimmune myocarditis and 
DCM still remain limited. Therefore, the cardiac muscle protein 
responsible for autoimmune myocarditis causing DCM must be 
identified. 
In the present investigation, a systematic study was carried out 
to characterize the 150 kD C-protein autoantigen which is known to 
induce autoimmune myocarditis leading to DCM. The autoantigen, 150 
kD human cardiac C-protein was characterized by ultraviolet 
spectroscopy, circular dichroism, thermal denaturation, SDS-PAGE and 
urea denaturation studies. The immunogenicity of C-protein was as 
certained by inducing polyclonal antibodies in experimental animals. 
The repertoire of specificities of induced antibodies was assessed by 
direct binding and competition ELISA. Commercially available calf 
thymus native DNA was purified free of protein and single standed 
regions and adducted to C-protein is presence of ROS and/or UV-B 
irradiation. The DNA C-protein adduct/photoadduct was characterized 
by nuclease SI sensitivity assay. Kinetic behaviour of addition of 
lysine residues (present in C-protein) at various irradiation time was 
studied in case of DNA C-protein photoadduct. The recognition of C-
protein and DNA C-protein adducts/photoadducts by DCM, SLE and 
induced anti C-protein antibodies was evaluated by direct binding and 
competition ELISA and band shift assay. 
"^xptvxxntninl 
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Materials: 
Calf Thymus DNA, Histone, Poly - D - lysine. Poly - L -
glutamate, Picryl sulfonic acid, bovine serum albumin, agarose NA, 
anti - human / anti - rabbit IgG alkaline phosphatase, anti - rat IgG 
horseradish peroxidase conjugate, ethidium bromide, coomassie 
brilliant blue G - 250 and R - 250, standard protein markers, sodium 
dodecyl sulphate, freund's complete and incomplete adjuvant and 
Tween - 20 were purchased from Sigma Chemical Company, U.S.A. 
Protein - A - Sepharose CL - 4B and Ficoll 400 were obtained 
from Pharmacia Fine Chemica l , Sweden. Tris (hydroxymethyl ) 
methylamine, EDTA (disodium salt), chloroform, isoamyl alcohol and 
h y d r o g e n p e r o x i d e were p u r c h a s e d from Q u a l i g e n s , India . 
Immunod iagnos t i c ki ts were purchased from St ' n g e n , India. 
Biochemical assay kits were purchased from Bayer i: gnistics. 
Polystyrene microtitre flat bottomed plates were purchased from 
Nunc, Denmark, p-nitrophenyl phosphate and Folin - Ciocalteau 
reagent were obtained from Centre for Biochemical Technology, New 
Delhi. Acrylamide, ammonium persulphate, bisacrylamide, N, N, N,' 
N - tetra ethyl methylene diamine (TEMED) were from Bio - Rad 
Laboratories, U.S.A. Diphenylamine and ethanol were chemically pure. 
All other chemicals were of highest analytical grade available. 
Equipment: 
Shimadzu UV - 240 s p e c t r o p h o t o m e t e r e q u i p p e d with 
thermoprogrammer and controller unit, ELISA microplate reader MR 
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- 600 (Dynatech, U.S.A..), Beckman DU - 640 spectrophotometer with 
densitomt'ter, Avanti 30 table top high speed refrigerated centrifuge 
(Beckman, U.S.A.), Ultraviolet lamp (Vilber Lourmat, France), agarose 
gel electrophoresis assembly (GNA - 100), Po lyacry lamide gel 
electrophoresis assembly (Bio - Rad, U.S.A.), gradient former model 
385 (Bio - Rad, U.S.A.), electroeluter (Bio - Rad, U.S.A.) HPLC 
(Beckman System Gold) and ELICO pH meter LI - 120 were the major 
equipments used in this study. 
Collection of sera: 
Normal human sera were collected from healthy subjects without 
evidence of DCM / SLE or other autoimmune disease. Sera from 
patients with dilated cardiomyopathy (DCM) and systemic lupus 
erythematosus (SLE) were obtained from the patients admitted to the 
Medical College Hospital of A.M.U. and from outdoor Cardiology and 
Medicine c l i n i c s , GB Pan t Hosp i t a l and AIIMS, New D e l h i , 
respectively. DCM patients were clinically diagnosed based on the 
definition and classification of cardiomyopathies (Richardson et al., 
1996). The SLE s^ra were obtained from the patients who had elevated 
levels of anti-DNA antibodies and met the revised criteria for the 
American Rheumatism Association (ARA) for the diagnosis of the 
d isease (Arnett et al . , 1988) . All serum samples were hea t 
decomplemented at 56 °C for 30 min, and were subsequently stored at 
-20 °C with 0.02% sodium azide as preservative. 
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DNA estimation: 
Colorimetric estimation of DNA was carried out according to 
Burton (1956) using diphenylamine reagent. 
a) Diphenylamine reagent: 
The reagent was prepared immediately before use by dissolving 
750 mg of recrystallized diphenylamine in 50 ml of glacial acetic 
acid containing 0.75 ml of concentrated sulphuric acid. 
b) Assay procedure: 
Varying amount of DNA adjusted to 1.0 ml with Phosphate 
Buffer Saline (PBS), pH 7.4, was mixed with IN perchloric acid 
and incubated at 70 °C in a water bath for 15 minutes. One 
hundred microliter of 5.43 mM acetaldehyde was added followed 
by 2.0 ml of diphenylamine reagent. The tubes were vortexed 
and allowed to stand at room temperature for 16-20 hr for colour 
development. Absorbance was recorded at 600 nm. The DNA 
concentration in the unknown sample was determined from the 
standard plot constructed by employing O-IOO i^g of purified calf 
thymus DNA. 
Protein Estimation: 
Protein was estimated by the method of Lowry et al. (1951) and 
Bradford (1976). 
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A. Protein estimatian by Folin-Phenol reagent: 
This method of protein estimation utilises alkali (to maintain 
high pH), Cu^ ions (to chelate proteins) and tartarate (to keep 
the Cu^^ions at high pH). 
a) Folin-ciocalteau reagent: 
The reagent was purchased from Cent re for Biochemical 
Technology, New Delhi (India). It was diluted with distilled 
water in the ratio of 1 : 4 before use. 
b) Alkaline copper reagent: 
The components pf alkaline copper reagent were: 
i) Two percent sodium carbonate in 0.1 M sodium hydroxide, 
ii) 0.5 percent copper sulphate in 1.0 percent sodium potassium 
tartarate. 
The working reagent was prepared afresh by mixing components 
(i) and (ii) in the ratio of 50 : 1. 
c) Procedure: 
To 1.0 ml of protein sample was added 5.0 ml of alkaline copper 
reagent, the contents were mixed and left at room temperature 
for 10 min. Then 1.0 ml of Folin-ciocalteau reagent was added 
and after 30 min. the absorbance was monitored at 660 nm. The 
protein content of unknown samples were determined from a 
standard plot constructed against bovine serum albupiin. 
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B. Protein estimation by Bradford method: 
This colorimetric assay is performed under acidic condition. The 
colour change occurs when Coomassie Brilliant Blue G-250 
binds strongly to protein hydrophobical ly and at posi t ively 
charged groups. In the environment of these positively charged 
groups, protonation is suppressed and a blue colour is observed. 
Binding of dye protein causes a shift in absorption maximum of 
the dye from 465 to 595 nm and it is the increase in absorption 
which is read at 595 nm which is monitored. 
a) Dye preparation: 
One hundred milligram of Coomassie Brilliant Blue G-250 was 
dissolved thoroughly in 50 ml of 95% double distilled ethanol. 
To this solution was added 100 ml of 85% (v/v) orthophosphoric 
acid. The resulting solution was diluted to a final volume of 
one litre. It was filtered before use. 
b) Protein assay: 
Solution containing 0-100 ^g protein in a volume of upto 0.1 
ml was pipetted into test tubes. The volume was adjusted to 1.0 
ml with appropriate buffer. Five milliliter of dye solution was 
added and the contents were vortexed. The absorbance was read 
at 595 nm within an hour against a reagent blank prepared from 
1.0 ml of buffer and 5.0 ml of dye solution. 
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Lysine est imat ion by TNBS method: 
Lysine estimation of the samples was determined by using 
trinitrobenzene sulphonic acid (TNBS) as described by Habeeb (1966). 
Varying concentrations of lysine (0-100 [ig) were diluted with 
distilled water to a final volume of 1.0 ml. To this was added 1.0 ml 
of 4% N a H C 0 3 , pH 8.5 and 1.0 ml of 0 . 1 % TNBS solution. The 
reaction mixture was incubated for 2 hrs at 37 °C. Subsequently, 1.0 
ml of 10% SDS was added to solubilize the protein and to prevent its 
precipitation on addition of 0.5 ml of IN HCl. The colour intensity 
was recorded at 335 nm against a blank treated in the same manner 
except that it contained 1.0 ml of water instead of lysine solution. 
The lysine content in the unknown samples was determined from the 
standard plot constructed against L-lysine. 
Isolation of 150 kD C-protein from human heart: 
Acetone powder of human heart was prepared by the method of 
Horecker et al. (1955). Seventy five grams of frozen left ventric 1 
was pulverized and homogenized in 5 volumes of chilled acetone. The 
material was filtered through suction on a Buchner funnel using 
Whatman filter paper No. 1. The semi-dry filter cake was again 
homogenized as described above and was subsequently washed several 
times with chi l led acetone and dried at room temperature. The 
connective tissue was screened out and the remaining acetone powder 
was stored at -20 °C. 
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Extraction of acetone powder was carried out as described by 
Kurata and Tan (1976). The acetone powder was extracted with 10 
volumes of PBS, pH 7.4 for 4 hrs at 4 °C with slow continuous stirring. 
The solution was centrifuged at 10,000 rpm for 15 min. and the 
supernatant was stored in small aliquots at -20 °C. 
Gel e lectrophores is : 
Polyacrylamide slab gel electrophoresis: 
Polyacrylamide slab gel electrophoresis was performed under 
denaturing conditions as described by Laemmli (1970). The following 
stock solutions were prepared : 
i) Stacking gel buffer 0 5 M Tris-HCl, pH 6 8 
ii) Resolving gel buffer 3 0 M Tris-HCl, pH 8 8 
iii) Reservoir buffer 0 025 M Tris, 0 192 M glycine, pH 8 3 
iv) Acrylamide-Bisacrylamide (30 0 8) 
Thirty grams acrylamide and 0.8 g bisacrylamide were dissolved 
in distilled water to a total volume of 100 ml. The solution was stored 
at 4°C in an amber coloured bottle. 
v) Sample buffer 
a) Six gram Tris was dissolved in 80 ml distilled water and pH 
adjusted to 6.8 with o-phosphoric acid. The final volume was 
brought to 100 ml. 
b) To 12.5 ml of the above solution was added 1 mg bromophenol 
blue and 12.5 ml glycerol. P-mercaptoethanol was added just 
before use. 
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Procedure: 
The glass plates (19 cm x 16 cm) soaked in chromic acid were 
thoroughly washed with tap water followed by final rinsing with 
distilled water and ethanol. Finally, the plates were dried and sealed 
with 1% agarose with 1.5 mm thick spacers. 
Recipe for 5 - 2 0 % Gradient Gel 
(Total volume: 24 ml) 
Solution 
Acrylamide-Bisacrylamide (30 : 0.8) 
Resolving gel buffer 
10% SDS 
1.5% ammonium persulphate 
TEMED 
esolving 
5% 
2 ml 
1.5 ml 
0.12 ml 
0.6 ml 
0.006 ml 
gel 
20% 
8 ml 
1.5 ml 
0.12 ml 
0.6 ml 
0.006 ml 
Final volume raised to 12 ml each with distilled water. 
2.5%) Stacking Gel 
(Total volume: 10 ml) 
Acrylamide-Bisacrylamide (30 : 0.8) 
Stacking gel buffer 
10% SDS 
1.5% ammonium persulphate 
TEMED 
1.25 ml 
2.5 ml 
0.1 ml 
0.5 ml 
0.0075 ml 
Final volume raised to 10 ml with distilled water. 
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Recipe for 7.5% SDS-PAGE 
(Total volume: 10 ml) 
Acrylamide-Bisacrylamide (30 : 0.8) 
Resolving gel buffer 
10% SDS 
1.5% ammonium persulphate 
TEMED 
7.5 ml 
3.75 ml 
0.3 ml 
1.5 ml 
0.015 ml 
Final volume made upto 30 ml with distilled water. 
The reagents were mixed and poured between glass plates. The 
resolving gel was allowed to polymerize at room temperature. Later 
stacking gel was layered on top followed by comb insertion and the 
gel was left to polymerize at room temperature. In case of gradient 
gels, a gradient was formed with the help of a gradient former (Bio-
RAD, model 385) in case of resolving gel. After ensuring complete 
polymerization, the protein samples (25-50 mg) in one fourth volume 
of sample buffer were electrophoresed at 70 volts for 6-8 hrs at room 
temperature. The gel was stained by 0.25% Coomassie Brilliant Blue 
R-250 or with silver stain reagent. 
Silver staining was done by the method of Merril et al (1983). 
Briefly, the gel was incubated in 40% methanol, 12% acetic acid for 
45 min. followed by incubation in 50% ethanol for 30 min. Next the 
gel was treated with 0.02% Hypo (sodium thiosulfate) for one min. 
After washing with distilled water, the gel was placed in 0.2% silver 
50 
nitrate (with 0 .05% v/v formaldehyde). After subsequent washing with 
distilled water, the gel was transferred to a 6% solution of sodium 
carbonate (with 0 .15% v/v formaldehyde). After colour development, 
the gel was washed with distilled water and the reaction was arrested 
by treating the gel with 3% v/v acetic acid and 5% v/v methanol. All 
the reagents used in this procedure were freshly prepared. 
Gel dens i tometry: 
The electrophoresed stained gels having an array of protein 
bands , r ang ing from low to high m o l e c u l a r weights were 
densitometrically scanned on a DU-640 spectrophotometer equipped 
with a densitometer at a fixed wavelength of 550 nm. 
Electroelution: 
The electrophoresed 150 kD C-protein band from human heart 
was carefu l ly s l i ced off from the gel and was subjec ted to 
electrophoretic transfer in an electroelution chamber equipped with 
BT-1 and BT-2 membranes (BIO-RAD). The electroelution was carried 
out in TBS (150 mM Tris-HCl, 175 mM NaCl), pH 7.4, containing 
20% methanol) at 150 volts for 5 hours at room temperature. The 
electroeluted 150 kD C-protein was dialyzed against distilled water 
and stored at -20 °C. Prior to storage for further s tudies , i ts 
homogeneity was reassessed by PAGE. 
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CD measurements: 
Circular dichroism measurements were carried out at 25°C on a 
Jasco spectropolarimeter model J - 720 using a SEKONIC X - Y plotter 
(model SPL - 430 A), NESLAB water bath model RTE 110 and quartz 
cell of path length 0.1 cm or 1.0 cm. Other experimental conditions 
were, sensitivity 5 mdeg, response time 0.5 s e c , scan speed 20 nm / 
min. and aresolution of 1.0 nm. The mean residue ellipticity [9] of a 
protein was calculated using the expression. 
[0] = 0 / ( 1 0 n X Cp X 1) 
Where 0 is the observed ellipticity in mdeg. n the number of 
aminoacid residues in the protein whose molar concentration is Cp 
and 1 is the path length in om. 
High performance liquid chromatography (HPLC): 
The electoreluted 150 KD C protein (from human heart) was 
further purified by HPLC using a sephader G - 200 column. The 
running buffer was PBS, pH 7.4. 
Agarose gel electrophoresis of DNA: 
Agarose gel was prepared by bringing 1% agarose NA to molten 
state in electrophoresis buffer (0.04 M Tris acetate, pH 8.0 containing 
0.002 M EDTA). Molten agarose was poured on the gel tray and 
allowed to solidify for one hour at room temperature. The DNA 
samples in one tenth volume of stop-mix (30% ficoll, 0 .025% xylene 
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cyanole FF and 500 mM EDTA in 10 times concentrated TAE buffer) 
were electrophoresed for 2-4 hrs at 30 mA in the same buffer. The gel 
was stained with ethidium bromide (0.5 \ig/m\). 
Preparation of DNA - C-protein adducts: 
a) Preparation of DNA - C protein photoadducts: 
Calf thymus DNA, free of histones and single stranded regions 
was mixed with HPLC purified C protein in the ratio of 1:2 in 
PBS, pH7.4 and incubated at 2hrs. at 37°C. The complex was 
subjected to UV-B irradiat ion for 30 min. at 254 nm. The 
temperature during irradiation was kept constant at 25 + 1°C by 
water curculation. Native DNA, unirradiated DNA - C protein 
complex, unirradiated C protein, irradiated DNA and irradiated 
C protein were used as controls. 
b) P repa ra t ion of DNA - C - protein adduc ts in presence of 
reactive oxygen species (ROS): 
ROS induced photoupling of C protein to the genetic material 
(DNA) was carried out in the presence of hydroxyl radical ( OH) 
generated by hydrogen peroxide (1.51 M) in presence of UV - B 
irradiation (254 nm) DNA - C protein complex was also formed 
only in the presence of hydrogen peroxide (1.51M). Purified calf 
thymus DNA and C protein were mixed in the ratio of 1:1 in 
PBS, pH 7.4. Similar amounts of native DNA, unirradiated C 
protein, irradiated DNA and irradiated C protein were used as 
controls. 
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All the treated samples were extensively dialyzed in PBS, pH 
7.4. The modif ied and unmodified samples were subjected to 
electrophoresis on 1% agarose using Tris acetate EDTA buffer, pH 8.0 
for 2 hrs. at 30 mA. The gel was stained with ethidium bromide (0.5 
^g / ml) and was photographed under UV illumination. 
Time course kinetic stsudy of formation of nDNA - C - protein 
photoadduct: 
The kinetic behaviour of photoaddition was assessed in order to 
determine the frequency of C protein photo cross linked to DNA. The 
DNA - C protein complex was subjected to UV - B irradiation (254 
nm) for various time intervals (10 - 30 min). Unirradiated DNA - C 
protein complex was used as control. The DNA - C protein photo 
adducts were precipi ta ted in two volumes of cold ethanol . The 
precipi ta te was col lec ted by centrifugation and dissolved in I.O 
ml of PBS, pH 7.4. The bound prote in was e s t ima ted in the 
photoadducts (Bradford et al, 1976). The lys ine con ten t in the 
s amp le s was a s s e s s e d by c o l o r i m e t r i c me thod u s ing TNBS 
(Habeeb, 1966). 
Kinetic analysis of the photoaddition reaction was performed 
by the method of Warren et al (1974) using first order rate equation. 
-In ( V a - Vt) - a + kt 
Where Vaand Vt are the lysine molecules photobound at infinity 
(30 min.) and at a particular time t respectively. The -In (Va - Vt) 
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values were plotted against the irradiation time t and the slope yielded 
the apparent first order rate constant k for the photoaddition process. 
Characterization of adduct by nuclease SI digestion: 
The formation of DNA - 150 KD C - pro te in adduct was 
characterized by SI nuclease digestion followed by gel electrophoresis. 
a) One percent agarose: 
Agarose (.3g) in 30 mix TAE buffer, pH 8.0 was brought to 
molter state and after cooling to 50° C was poured onto a 
horizontal gel tray of GNA - 100 electrophoresis apparahis 
(Pharmacia Sweden) and was left at room temperature for 
complete solidificatin. 
b) Electro buffer: 
40 mM Iris - acetate and 2mM EDTA, pH 8.0 (TAE buffer) 
c) Treatment of adduct with SI nuclease: 
One jig of DNA - 150 kD C -protein adduct and riative DNA 
were treated with SI nuclease (20 units of S1 nuclease per jig of 
adduct) in acetate buffer for 30 minutes at 37°C. The reaction 
was stopped by the addition of one tenth volume of 0.2 M EDTA, 
pH 8.0. 
d) Sample p repara t ion : 
The treated and untreated samples in low ionic strength and at 
concentrations of less than 1 jig / ml were loaded. The sample 
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contained one tenth volume of 30% Ficoll (Pharmacia), 0.025% 
bromophenol blue, 0.5 M EDTA and lOX electrophoresis buffer. 
e) Running conditions: 
30 mA for 2 hours. 
f) Staining: 
The electrophoresed gel was stained with ethidium bromide (0.5 
M-g / ml). 
Urea - SDS - PAGE-: 
Urea - SDS - PAGE was performed according to the method of 
Swank and Munkres, (1971). The following stock solutions were 
prepared : 
i) Acrylamide : Bisacrylamide : 12.5 g acrylamide 
(10 : 1) 1.25 g bisacrylamide 
dissolved and made upto 50 
ml with distilled water. 
ii) Gel buffer stock 1% SDS 
1.0 M H^PO^ (adjusted to 
pH 5.0 with Tris base) 
iii) Reservoir buffer stock 0 .1% SDS 
0.3M H,PO, 
(adjusted to pH 6.8 with 
Tris base) 
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iv) Sample buffer 1% SDS 
8 M Urea 
1% 2-mercaptoethanol 
O.IM H,PO, 
(adjusted to pH 6.8 with Tris 
base) Bromophenol blue 
added to 0.002% (w/v)final 
concentration. 
RECIPE 
12.5% Resolving gel 
Acrylamide : Bisacrylamide (1:10) 15.0 ml 
Gel buffer stock 3.0 ml 
Urea 14.4 g 
6% ammonium persulfate 0.3 ml 
(freshly prepared) 
TEMED 0.02 ml 
The volume is made upto 30 ml with distilled water. 
3.75% Stacking gel 
Acrylamide : Bisacrylamide (1:10) 1.5 ml 
Gel buffer stock 0.3 ml 
Urea 1.44 g 
6% ammonium persulfate 0.03 ml 
(freshly prepared) 
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TEMED 0.002 ml 
The final volume is made upto 10 ml with distilled water. 
Procedure: 
A low concentration gel of 3.75% was layered over 12.5% gel, 
with the same buffer composition. This is done to avoid breakage of 
sample well divis ions which become very br i t t le due to high 
crosslinking of resolving gel. The gels were run for 6-8 h at 70 volts. 
Stainer: 
After electrophoresis, the gels were stained for one hour in: 
methanol : water : glacial acetic acid in ratio of 5 : 5 : 1 
Coomassie Brilliant Blue R 250 
Destainer: 
Destaining is by diffusion in 
12.5% isopfopanol 
10% acetic acid. 
Urea SDS-PAGE was also pe r fo rmed by doing va r ious 
alterations. 
UREA - SDS-PAGE 
(with varying concentrat ions of urea) 
A gradient gel of 1 M to 10 M urea was polymerized 
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RECIPE 
Resolving gel (12.5%) 
Acrylamide : Bisacrylamide (1:10) 
Gel buffer stock 
Urea 
6% ammonium persulfate 
(freshly prepared) 
TEMED 
1 M Urea 
: 2 ml 
0.4 ml 
0.24 g 
0.04 ml 
0.0027 ml 
10 M Urea 
2 ml 
0.4 ml 
2.4 g 
0.04 ml 
0.0027 ml 
The final volume is made upto 4 ml each with distilled water. 
Stacking gel (3.75%) 
Acrylamide : Bisacrylamide (1:10) 
Gel buffer stock 
Urea 
6% ammonium persulfate 
(freshly prepared) 
TEMED 
0.3 ml 
0.06 ml 
0.36 g 
0.02 ml 
0.0016 ml 
The final volume is made upto 2 ml with distilled water. 
UREA - SDS-PAGE 
(with varying concentrations of acrylamide : bisacrylamide) 
A 5-20% gradient gel of acrylamide : b i sacry lamide was 
polymerized. 
Gel buffer stock 
Urea (8 M) 
6% ammonium persulfate 
(freshly prepared) 
TEMED 
0.4 ml 
1.92 g 
0.04 ml 
0.0027 ml 
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RECIPE 
Resolving gel (5-20%) 
5% 20% 
Acrylamide : Bisacrylamide(l:10) 0.6 ml 2.4 ml 
0.4 ml 
1.92 g 
0.04 ml 
0.0027 ml 
The final volume is made upto 4 ml each with distilled water. 
Stacking gel (3.5%) 
Acrylamide : Bisacrylamide : 0.3 ml 
Gel buffer stock : 0.06 ml 
Urea : 0.36 g 
6% ammonium persulfate : 0.02 ml 
TEMED : 0.0016 ml 
The final volume is made upto 2 ml with distilled water. 
Absorption - temperature scan: 
Thermal native to coil transition analysis of native Cardiac C 
protein and native IgG was carried out in order to assess / probe their 
comparative thermal stability in view of the established fact that both 
of them possess similar domains. 
Native C pro te in and nat ive IgG were sub jec ted to heat 
denaturation on a Shimadzu UV-240 spectrophotometer coupled with 
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a temperature programme and controller assembly (Hasan and Ali, 
1990). The samples were melted from 30°C to 100°C at a rate of 1°C/ 
min. Prior to scanning, the samples were temperature-equilibrated at 
30°C for 10 minutes. The change in absorbance at 280 nm was recorded 
with increasing temperature. Percent denaturation was calculated using 
the following equation : 
% denaturation = AT-ASO X 100 
Amax-A30 
where. 
AT = Absorbance at a temperature T°C 
Amax = Final maximum absorbance on the completion of 
denaturation 
A30 = Initial absorbance at 30 °C. 
Thermodynamic analysis of 150 kD cardiac protein as well as 
native IgG: 
The thermal transition of proteins from native to denatured state 
was characterized as a single variable, fo, the fraction of protein in 
the denatured state. The percent loss in absorbance was used as 
experimental variable to follow the transition. At any given point along 
the transition curve, the observed percent change in absorbance was 
related to the fraction of protein in the denatured state, by the 
following expression 
fo = (A)obs - (A)N 
( A ) D - (A)N 
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where, (A)obs, (A)N and (A)D represent the percent loss in 
absorbance in any observed, native and fully denatured s ta tes , 
respectively. Since each experimental value of (A)obs will give a 
unique value of (A)D, the later was used to construct transition curves 
for the thermal denaturation of proteins. 
Since the unfolding/denaturation of proteins is a more than one 
step process due to various factors, the initial and final states of 
thermal denaturation of proteins were related to apparent equilibrium 
constant, defined as 
Kapp = (A)obs - (A)N 
( A ) D - (A)obs 
The free energy change, AG^, for the thermal reaction (native 
coil conformation) was calculated by using the relationship 
AGD = - RT InKapp 
where, Kapp is the equilibrium constant, R is the gas constant 
(8.314 J/mol/deg) and T is the absolute temperature. 
Immunization schedule: 
Heal thy female rabbi t and ra t s were immunized with 
electrophoretically pure 150 kD C-protein antigen emulsified in an 
equal volume of Freund's complete/incomplete adjuvant as described 
earlier (Hasan and Ali, 1990). Injection dose of 100 \ig and 50 ng 150 
kD C-protein was given to rabbit and rats, respectively. 
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The first injection eliciting primary response was given in 
Freund's complete adjuvant, followed by three successive boosters 
which were given after two weeks at weekly intervals in Freund's 
incomplete adjuvant. The volume of the emulsion to be injected was 
kept as 1.0 ml and 0.5 ml for rabbit and rats, respectively. 
Blood was drawn from experimental animals by cardiac puncture 
after the third booster and the antibody activity in the immune serum 
was evaluated by ELISA . Prior to immunization, pre-immune serum 
was c o l l e c t e d for employ ing it as c o i r e s p o n d i n g con t ro l in 
immunological studies. 
Isolation of IgG by affinity chromatography: 
Protein A Sepharose CL-4B (1.5 g) was employed as affinity 
matrix. First ly, it was swelled in 0.01 M PBS, pH 7.4 at room 
temperature for 12 hrs. The swelled matrix (about 5.0 ml) was washed 
with PBS and packed in a column of 0.9 cm x 15 cm. The packed 
column was washed with 0.1 M sodium citrate, pH 3.0 in order to 
elute any bound material. This was followed by equilibration of the 
packed matrix with 5 volumes PBS, pH 7.4. Serum diluted with equal 
volume of PBS, pH 7.4 was loaded onto the column and allowed to 
bind at a flow rate of 20 ml/hr. Unbound protein was eliminated with 
PBS and absorbance of effluent monitored till a negative absorbance 
was obtained at 280 nm The bound IgG was eluted with 0.58% acetic 
acid in 0.85% sodium chloride. To prevent the effect of acidic elution 
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buffer on IgG, fractions were collected in 1 M Tris-HCl, pH 8.5. The 
fractions containing IgG were monitored at 251, 260, 278 and 280 
nm. The fractions with the appropriate ratio for mammalian IgG (2.5-
3.0) were dialyzed in 0.01 M PBS, pH 7.4. 
To check the purity of IgG, the samples were subjected to 7.5% 
SDS-PAGE. 
Immunoaffinity purification of ant ibodies: 
a) CNBr activation of Sepharose 4B: 
15 ml of supplied Sepharose 4B was suspended in distilled water, 
and then washed with 300 ml of cold distilled water on a sintered 
glass funnel (porosity G-2). Moist gel (about 10 g) in 10 ml of 
2.0 M sodium carbonate was kept in ice - NaCl bath placed on a 
magnet ic s t i rrer . One gram cyanogen bromide in 0.8 ml 
acetonitrile was slowly added to the gel with gentle stirring. 
The reaction was allowed for 12 min. and after that the reaction 
product was filtered on a sintered glass funnel, washed with 400 
ml of cold 0.01 M sodium bicarbonate and resuspended in 10 ml 
of the same buffer. The unreacted CNBr was treated with ferrous 
sulphate to convert it into harmless ferrocyanide. All steps were 
carried out in a fumehood chamber (Ali, 1984). 
b) Poly-L-lysine coupling to activated Sepharose 4B: 
The method descr ibed by Wilchek (1973) was fo l lowed. 
Immediately after CNBr activation of gel, equal volume of Poly-
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L-lysine (100 mg in 10 ml of 0.1 M sodium bicarbonate) was 
added to the activated gel and kept at 4 °C for 12 hrs with slow 
stirring. The buffer was drained out and the gel was washed 
successively with 100 ml each of (i) cold distilled water, (ii) 
0.1 N HCl, (iii) 0.1 M sodium bicarbonate and (iv) distilled water 
till neutral. Finally the gel was suspended in 40 ml of 0.15 M 
acetate buffer, pH 4.5. The extent of Poly-L-lysine depletion 
due to its covalent coupling with activated Sepharose 4B was 
calculated by TNBS estimation of lysine in the drained effluent 
as described by Habeeb (1966). 
c) Affinity purifiction of ant ibodies: 
DNA-[polylysyl-Sepharose 4B] was prepared as described by 
Nicotara et al. (1982) with a slight modification. Previously 
prepared 20 ml po ly ly sy l -Sepha rose 4B was packed and 
equilibrated with 25 ml acetate buffer in a mini column (1.5 cm 
X 5 cm). Purified DNA (12.5 ml of 100 \ig/m\) in acetate buffer 
was passed through the gel and unbound material was eliminated 
with PBS, pH 7.4. Heat decomplemented SLE serum dialyzed 
against and diluted (1 : 10) with PBS was passed through the 
column. Unbound proteins were washed with PBS and the bound 
antibodies were eluted with linear ionic strength gradient of 
0.15-3.0 M sodium chloride in 0.01 M phosphate buffer. pH 7.4. 
The fractions were monitored at 251 nm. 260 nm, 278 nm and 
280 nm. 
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d) Regeneration of affinity column: 
The column was r e g e n e r a t e d severa l t imes by wash ing 
successively with 50 ml each of the following (i) distilled water, 
(ii) 0.1 N HCl, (iii) 0.1 M sodium bicarbonate, and (iv) distilled 
water till neutral. 
Enzyme linked immunosorbent assay (ELISA): 
The antibodies were detected and quantitated by ELISA using 
polystyrene flat bottom microtiter plates as solid phase (Alam and Ali, 
1992) . The method described by Ali et al. (1985) and Arif et al. (1994) 
were followed for the assay. 
Buffers: 
i) Tris buffered saline (TBS), pH 7.4 : 
10 mM Tris, 150 mM NaCl, pH 7.4 
ii) Tris buffered saline Tween-20 (TBS-T), pH 7.4 : 
20 mM Tris, 144 mM NaCl, 2.68 mM KCl and 500 ^1 Tween-20, 
pH 7.4. 
iii) Bicarbonate buffer, pH 9.6 : 
15 mM sodium carbonate, 35 mM sodium bicarbonate, pH 9.6. 
iv) a) Substrate buffer, pH 9.6 : 
(for a n t i - human / anti rabbit IgG alkaline phosphate conjugate) 
15 mM sodium carbonate, 35 mM sodium bicarbonate and 2 mM 
magnesium chloride, pH 9.6. 
substrate : 0.5 mg/ml of p-nitrophenyl phosphate 
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b) Substrate buffer, pH 5.0 : 
(for anti rat) IgG horse radish peroxidase conjugate) 
50 mM citric acid, 50 mM di-sodium hydrogen orthophosphate 
dihydrate (Na2HP0^.2H20) 
substrate : 0.5 mg/ml of o-phenylene diamine. 
Procedure: 
Polystyrene microtiter plates were incubated with 100 |ul of 
protein antigen (50 ng/ml in carbonate/bicarbonate buffer, pH 9.6) for 
two hours at room temperature followed by overnight incubation at 
4°C. The plates were washed thrice with TBS-T and the unoccupied 
sites were blocked by 150 pi of 1.5% BSA in TBS for four hours at 
room temperature. Varying dilutions of sera diluted in TBS were added 
to antigen coated as well as control wells. The ant igen-ant ibody 
interaction was allowed to proceed for two hours at room temperature 
followed by overnight incubation at 4°C and subsequently the plates 
were washed four times with TBS-T in order to remove the uninteracted 
antibodies. Bound antibodies were assayed by means of appropriate 
anti-immunoglobulin alkaline phosphatase / anti-immunoglobulin horse 
radish peroxidase conjugate using p-ni t rophenyl p h o s p h a t e / o-
phenylene diamine as substrate, respectively. The reaction was stopped 
by 3N NaOH / 5 N H^SO_j, respectively and the absorbance of each 
well was monitored at 410/490 nm on an ELISA microplate reader. 
Each sample was coated in duplicate and the results were expressed 
as a mean of Atest - Acontrol. 
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For nucleic acid antigen, the polystyrene microtiter plates were 
preincubated with 100 |il of poly D-lysine solution (50 ^g/ml in 
dist i l led water) for 30 minutes at RT so as to increase antigen 
immobilization (Arif et al., 1994). The plates were washed thrice with 
TBS and coa ted with 100 fil of nuc le ic acid a n t i g e n ( s ) at a 
concentration of 2.5 ng/ml in TBS (pH 7.4) for two hours at room 
temperature followed by overnight incubation at 4°C. After eliminating 
the unbound antigen by washing thrice with TBS-T, the unoccupied 
positively charged polylysine molecules were neutralized by saturating 
the plates with 100 1^ of negatively charged poly-L-glutamate (50 \ig/ 
ml in TBS, pH 7.4) for two hours at room temperature. The rest of the 
steps were same as described above. 
Inhibit ion ELISA: 
The antigen binding specificity of antibody was determined by 
inhibition experiments (Hasan et al., 1991). Varying concentration of 
inh ib i tors (0-20 ^g/ml) were mixed with a constant amount of 
antiserum/IgG. The mixture was incubated for two hours at 37°C 
followed by overnight incubation at 4°C. The resulting immune 
complex was employed in the immunoassay instead of serum. The rest 
of ihe steps were as in Direct binding ELISA. The resul ts were 
expressed as percent inhibition 
% Inhibition - 1 - A inhibited x 100 
A uninhibited 
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Band shift assay: 
The antibody binding to ROS modified and unmodified DNA -
C p ro t e in a d d u c t s / p h o t o a d d u c t s were ana lyzed by a l t e red 
electrophoretic mobility on agarose gel (Sanford et. al., 1988). A 
constant amount of antigen (1.0 ng) was allowed to interact with 
varying amounts of antibody (0-150 ng). The interaction was allowed 
to proceed for 2 hrs at 37°C and overnight at 4°C. This resulted in the 
formation of immune complex (IC). Two microliter dye solution was 
added to each assay tube and the complex was electrophoresed on 1% 
agarose gel for 2 hrs at 30 mA using Tris-acetate EDTA buffer, pH 
8.0. The electrophoresed gels were stained with ethidium bromide (0.5 
^g/ml) and were visualized and photographed under UV illuminator. 
Appropriate controls were also run simultaneously. 
Estimation of glucose in serum of DCM patients: 
Autopak reagent kit was used for in vitro quantitative estimation 
of glucose in serum (Trinder, 1969). 
In this method, glucose is oxidised by glucose oxidase (GOD) 
into gluconic acid and hydrogen peroxide. 
Glucose + 0 , > Gluconic acid +UXf^. 
Hydrogen peroxide in presence of peroxidase oxidizes the 
chromogen 
4- amino phenazone/H^O, + Phenolic compound + 4 amino 
phena zone > Red compound + 2H O Phenolic compound to a red 
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coloured compound . The in tens i ty of red co lour p roduced is 
proportional to the glucose concentration. 
b) Assay procedure: 
One ml of working solution was added to 10 //I of sample volume 
and incubated for 15 minutes at 37°C. The samples were read at 505nm 
against reagent blank. 
a) Reagents: 
i) Tablets: Buffer / enzymes (GOD, POD) / Chromogen 
(4 aminophenazone, phenolic compound) 
ii) Standard: Glucose lOOmg/dl 
One tablet was dissolved in 50ml of distilled / deionized water 
to prepare the working solution. 
Estimation of Cholesterol in Serum of DCM Patients: 
Autopak r eagen t kit was used for in v i t ro quan t i t a t i ve 
determination of cholesterol in serum (Tartuttor and Gunter, 1974). 
In this method, cholesterol esters are hydrolysed by cholesterol 
ester hydrolase to free cholesterol and fatty acids. The free cholesterol 
produced and pre existing one are oxidised by cholesterol oxidase to 
A^  - cholestenone and hydrogen peroxide. 
CEH Cholesterol esters > cholesterol + fatty acids . 
Cholesterol + 0 , > A^  cholestenone + H ,0 , . 
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Hydrogen peroxide in the presence of peroxidases, oxidize the 
chromogen (4 aminophenazone / phenol) to a red coloured compound. 
H2O2+ 4 aminophenazone / phenol > Red couloured compound. 
a) Reagents: 
i) Buffer / Enzymes / Chromogen 
ii) Phenol 
iii) Standard : Cholesterol - 200mg / dl 
Reagent (i) and (ii) were mixed in the ratio of 1:1 (V/V) to 
prepare working solution which was stored in a dark bottle at 2 - 8° C 
b) Assay procedure: 
One ml of working solution is added to 10 //I of serum and the 
reaction mixture was incubated for 5 min. at 3 7'^C. The samples were 
read at 510 nm against reagent blank. 
Estimation of uric acid in serum of DCM patients: 
Autopak reagent kit was used for in vitro quantitative estimation 
of uric acid in serum (Fossati et al., 1980). 
In this method, uric acid is converted by uricase into allantoin 
and hydrogen peroxide which in presence of peroxidase (POD) 
oxidizes the chromogen (4 - aminophenazone / 3,5 dichloro hydroxy 
benzene sulphonic acid) to a red coloured compound. 
uricase 
Uric acid + O2+ H^O > allantoin +C0^+ H^O^ 
2H2O2+ 4 - aminophenazone + DHBS > Red coloured + H2O 
compound 
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a) Reagents: 
i) Buffer / Enzymes / 4 - aminophenazone / Potassium ferrocyanide. 
ii) 3,5 - Dichloro - 2 - hydroxy benzene sulphonic acid / surfactant, 
iii) Standard: Uric acid - 6 mg / dl 
The working solution was prepared by mixing 10ml of reagent 
(ii) to one vial of reagent (i) and this was stored at 2 - 8°C. 
b) Assay procedure: 
One ml of working solution was added to 30 ^1 of serum. The 
reaction mixture was incubated at room temperature for 15 min and 
read at 505 nm against reagent blank. 
Estimation of C reactive protein (CRP) in serum of DCM patients: 
Stangen C - PROTEST kit was used for in vitro quantitative 
and semi - quantitative determination of C - reactive protein in serum 
samples in the acute phase of infection (Shire et al., 1981). 
Stangen C - PROTEST is a rapid latex agglutination procedure 
for the direct detection and semiquantitation on slide of C - reactive 
protein in human serum samples. The reagent, a smooth suspension of 
latex par t i c les coated with speci f ic an t ihuman CRP ant ibody, 
agglutinates in the presence of CRP in the patients serum, a positive 
result is indicated by the presence of agglutination and vice versa. 
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Reagents: 
i) CRP latex reagent 
ii) Positive control 
iii) Negative control 
Assay procedure: 
A) Qualitative Test: 
One drop of each control and 50 |il of test serum was placed 
onto separate circles on the slide. One drop of CRP reagent was 
added to each sample and mixed well over the entire encircled 
area by mixing sticks. The slide was rotated gently and slowly 
and after 2 min., it was observed for agglutination. 
The presence of a visible agglutination on or before 2 min. 
indicate a content of CRP > 6mg / L. The sample positive for 
CRP was titred by semiquantitative method. 
B) Semi quantitative test: 
Serial two fold dilutions of positive sample were prepared in 
normal saline . The rest of the procedure was same as in 
qualitative test (A). 
The serum titer was defined as the highest dilution showing 
visible agglutination of latex particles. The approximate CRP 
level present in the sample was obtained by the formula: 
CRP (mg / L) - S x D 
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S = Limit of sensitivity i.e. .6 mg / L 
D = Highest dilution of serum sample showing agglutination. 
Detection of rheumatoid factor (RF) in serum of DCM patients: 
Stangen RHEUMA TEST kit was used for in vitro quantitative 
detection of Rheumatoid factor in serum samples (Linker and Williams 
Jr, 1985) 
RHEUMATEST Kit c o n s i s t s of a smooth s u s p e n s i o n of 
polystyrene la tex pa r t i c l e s coa ted with a pur i f ied human IgG 
molecules. The pre diluted serum sample to be tested was mixed with 
the latex particles and allowed to react. The human IgG forms complex 
with rheumatoid factor present in serum and results in an agglutination, 
an indicator for positive result and vice versa. 
a) Reagents: 
i) RF latex reagent 
ii) Positive control (prediluted) 
iii) Negative control (prediluted) 
iv) Specimen diluent 
Assay procedure: 
Quantitative test: 
To 50 \i\ of specimen diluent , 10 ^1 of test serum was added 
and mixed well on the slide. One drop of latex reagent was added to 
the test samples as well to drop each of positive and negative control. 
The reaction mixture was mixed well on be entire circle and the slide 
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was rotated gently for observation of agglutination at the end of 2 
min. Agglutination observed on or before 2 min. showed presence of 
Rheumatoid factors in the serum. 
JR^suIts 
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Isolation of 150 kD C- protein: 
¥ rotein antigens of different molecular weights in the total human 
heart extract (THHE) were separated on a 5 - 20% gradient SDS - PAGE. 
The electrophoresed results depicted in Fig.l inidicated a wide spectrum of 
protein antigens ranging from low to high molecular weights. In order to 
localize and isolate the 150 kD C protein which is known to induce 
myocarditis, the above electrophoresed SDS - polyacrylamide gel was sub-
jected to densitometric scanning. The densitometric scanned gels showing 
prominent bands of 150 kD C - protein were sliced off and subsequently 
cut into small pieces and thereafter subjected to e lec t roelut ion. The 
electroeluted pure 150 kD C - protein was further ascertained for its homo-
geneity by PAGE. The single band of 150 kD C - protein in PAGE revealed 
the inducing 150 kD C -protein antigen. In order to minimize or eliminate 
the chances or probability of undetectable impurities in the isolated pro-
tein antigen, the visibly pure electroeluted 150 kD C - protein was sub-
jected to HPLC (Fig.2). The electroeluted and subsequently HPLC purified 
150 kD cardiac C - protein was employed in the binding studies. 
Ethidium bromide (Et - Br) intercalat ion assay: 
The possibility of traces of DNA present in the total human heart ex-
tract (THHE) could not be ruled out. Thus, in order to ascertain and there-
after eliminate the possible presence of traces of DNA in THHE which could 
interfere in the binding studies, agarose gel electrophoresis was performed. 
Calf thymus dsDNA as a control along with THHE were loaded onto the 
wells and the gel was electrophoresed. As evident from Fig. 3, visualized 
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1^0 kP 
Iret-n 
Fig. I Electrophoretic pattern of total human heart extract (THHE) on 5 
20% gradient SDS - PAGE 
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^ 
Fig. 3 Agarose gel electrophoresis to show the absence of anv trace of DNA 
in THHE. 
Lane 1 (native DNA) Lane 2 (THHE) 
79 
after staining with Et - Br, only lane containing DNA as control showed 
fluorescence upon Et - Br intercalation, whereas no fluorescence was ob-
served in the lane containing THHE, thereby ruling out the possibility for 
the presence of trace amount of DNA in human heart extract. 
Ultraviolet and circular dichroic spectral analysis of 150 kD C - protein: 
Prior to immunological characterization, the purified 150 kD cardiac 
protein was subjected to ultraviolet and circular dichroic spectroscopy. The 
spectral curves showed a X max at 280 nm along with a shoulder at around 
289 nm. The Xmin was observed at 248 nm. The A26O / A295 ratio was 
computed out to be 1.49. It showed the characteristics of a typical dimeric 
protein (Fig. 4) . 
Thermal native to coil transition or unfolding study of 150 kD C - protein: 
Thermal denaturation of 150 kD C - protein and IgG as control were 
investigated in between 30°C and 95°C. The process was characterized by 
determining the percent fraction of protein in the denatured state at various 
temperatures. Increase in UV absorption at 280 nm was taken as a measure 
of thermal unfolding. As evident from Fig. 5, till 75° C thermal unfolding 
was found to be of a very low magnitude. Only 4.4 percent of the total 150 
kD C - protein underwent thermal unfolding till 75°C. Nearly half of the 
150 kD C - protein (i.e. 50%) was observed to have undergone thermal un-
folding at around 79.5°C. Further supplementation of thermal energy as 
evident from Fig. 5, exhibited a sharp transition in the partially unfolded C 
- protein to the fully unfolded state. Complete thermal unfolding was found 
1 0 -
80 
8 -
-10 
I 
_L _L 
210 220 230 2A0 250 
WAVELENGTH(nm) 
260 
Fig. 4 Circular dichroic spectra of 150 kD C protein 
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Fig: 5(A) Thermal unfolding profile of HPLC 
purified 150 kD human cardiac C-pro-
tein. 
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to be achieved at 87°C. Thus, as evident from the thermal unfolding curves, 
significant onset of unfolding was at around 77°C (around 9.19 percent 
unfolding) which spanned till 87°C i.e. the temperature at which 100% 
unfolding was obtained. Thus, the results indicated the effective thermal 
unfolding transition breath to the degree of lO^C (i.e. between 77°C to 87° 
C). Furthermore, the above data is indicative for the tremendous structural 
stability of the 150kD cardiac C-protein. Similar observation were also made 
for IgG (data not shown) which was used as control in view of the estab-
lished fact that both IgG as well as 150 kD C - protein have somewhat simi-
lar domains. It is to be pointed out that further supplementation of thermal 
energy above 87°C exhibited a decrease in absorbance at 280 nm. As evi-
dent from Fig.5, the absorbance at 87°C was 1.217 and that it was found to 
decrease gradually above 87°C. As evident, the A28O at 95°C was observed 
to be 0.565. Thus, at 95°C, nearly more than 50 percent of the absorbance 
recorded at 280 nm for 150 kD C - protein in the fully unfolded state (i.e. at 
87°C) was found to be lost. Thus a sharp hypochromic effect was observed 
at temperatures above the unfolded state of 150 kD C - protein. 
Thermodynamical analysis of 150kD C - protein: 
The high molecular weight cardiac C -protein was also characterized 
by means of thermodynamic analysis. The free energy of unfolding/dena-
turation (AG^) for 150kD C - protein was computed to be 12.363 K. cal. 
deg -• at 303°K (30°C) i.e. prior to thermal unfolding. As evident from the 
results, the free energy of denaturation / unfolding decreased linearly from 
30°C (303OK) to 78°C (351°K). The AG^^ at 78°C was computed to be 2.332 
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TABLE 1 
THERMAL DENATURATION OFlSOkD CARDIAC CPROTEIN 
TEMPERATURE 
°C 
30 
35 
40 
42 
45 
48 
50 
52 
55 
63 
65 
70 
72 
75 
77 
78 
79 
80 
81 
82 
83 
84 
85 
86 
87 
89 
90 
91 
92 
94 
95 
OK 
303 
308 
313 
315 
318 
321 
323 
325 
328 
336 
338 
343 
345 
348 
350 
351 
352 
353 
354 
355 
356 
357 
358 
359 
360 
362 
363 
364 
365 
367 
368 
^D 
0 000 
0 008 
0 022 
0 036 
0 038 
0 041 
0 046 
0 048 
0 051 
0 059 
0 067 
0 076 
0 086 
0 122 
0 254 
0 689 
1 222 
1 619 
2 029 
2 216 
2 468 
2 665 
2 743 
2 754 
2 762 
2 110 
1 792 
1 570 
1 343 
1 132 
1 132 
K, 
App 
0 000 
0 008 
0 022 
0 030 
0 039 
0 042 
0 048 
0 051 
0 054 
0 063 
0 072 
0 082 
0 095 
0 138 
0 341 
2 217 
-9 222 
-2 616 
-1 971 
-1 822 
-1 681 
-1 601 
-1 574 
-1 570 
-1 567 
-1 900 
-2 263 
-2,754 
-3 913 
-8 551 
0 370 
AG„ = - RT In K, 
D App 
(Kcal.deg') 
12 363 
9 932 
9 184 
8 576 
8 460 
7 984 
8 041 
7 960 
7 724 
7 393 
7 132 
6 752 
5 731 
3 131 
2 322 
-6 502 
-2 823 
-1 998 
-1 767 
-1 536 
-1 397 
-1 351 
-1 346 
-1 343 
-1 932 
-2 469 
-3 074 
-4 139 
-6 547 
3 041 
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TABLE 2 
THERMAL DENATURATION OF IgG 
TEMPERATURE 
»C •'K 
30 303 
35 308 
40 313 
45 318 
50 323 
55 328 
60 333 
65 338 
70 343 
75 348 
77 350 
78 351 
79 352 
80 353 
81 354 
82 355 
83 356 
84 357 
85 358 
86 359 
87 360 
88 361 
89 362 
90 363 
91 364 
92 365 
93 366 
94 367 
95 368 
96 369 
97 370 
98 371 
99 372 
100 373 
fo 
0 000 
-0 003 
-0 010 
-0 013 
-0 020 
-0 017 
0 014 
0 024 
0 034 
0 089 
0 166 
0 279 
0 393 
0 521 
0 669 
0 776 
0 883 
0 948 
1 010 
1 028 
1 048 
1 066 
1 083 
1 089 
1 086 
1 082 
1 079 
1 062 
1 052 
1 038 
1 000 
App 
0 000 
-0 003 
-0 010 
-0 014 
-0 020 
-0 017 
0 014 
0 025 
0 036 
0 098 
0 198 
0 388 
0 648 
1 086 
2 021 
3 462 
7 529 
18 333 
-97 667 
-37 250 
-21 714 
-16 263 
-13 083 
-12 154 
-12 600 
-13 083 
-13 609 
-17 111 
-20 333 
-27 364 
0 290 
AG„ = RT In K, 
D App 
(K cal deg-1) 
15 607 
12 564 
11 818 
10 993 
11 620 
12 351 
10 734 
9 700 
6 798 
4 752 
2 787 
1 281 
-0 246 
-2 089 
-3 696 
-6 026 
-8 707 
-13 752 
-10 887 
-9 289 
-8 440 
-7 802 
-7 600 
-7 730 
-7 867 
-8 009 
-8 73 5 
-9 291 
-10 234 
1 449 
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k.cal. deg '. The large positive AG^ values obtained at the initial stages of 
thermal unfolding which decreased linearly till 78°C is indicative for the 
folding of C - protein by ionic and hydrophobic interactions with probably 
intermittent presence of disulfide bonds. Furthermore, the results indicate 
that C - protein having domains similar to IgG is not that so thermodynami-
cally compact molecule as is native DNA, where due to stable stacking of 
the base pairs, a negative AG^is observed in the initial stages of thermal 
melting. Further elevation of thermal energy showed negative AGjj values 
for 150 kD C -protein . The AG^ values from 79«C to 94°C (i.e. 352°K -
367°K) were computed to be - 6.502 K.cal. deg ' and -6.547 K.cal. deg "'. 
The AGp values above 79''C decreased linearly till 89°C (362°C) followed by 
again an increase in the AG^ values till 94°C. The results are indicative for 
the complete thermal unfolding of the 150 kD C - protein at around 78°C or 
79°C. Due to the reason that 150 kD C - protein is having some what simi-
lar domains to IgG, comparative thermodynamical analysis between the two 
as also carried out. As evident from the results, IgG was found to be a 
thermodynamically more compact molecule than 150 kD C - protein. These 
thermodynamic parameters are depicted in Tables - 1 & 2. 
Urea denaturation studies: 
The 150 kD cardiac C protein and IgG were subjected to urea SDS-
PAGE at constant concentration of acrylamide (12.5%) and urea (8M), us-
ing an acrylamide (5-20%) and urea (I-IOM) gradient. A more or less simi-
lar picture emerged with both denaturing process where two prominent bands 
of more of less same molecular weights (Fig. 6) were observed. 
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(A) 
pi' n 1 r 
I 
Fig. 6 Electrophoretic pattern of C protein and IgG on urea-SDS-PAGE 
(A) 12.5% urea SDS - PAGE with 8M urea 
(B) 12.5% urea SDS - PAGE using a linear gradient of 1-10 M urea. 
(C) 5 - 20% urea SDS - PAGE using a linear gradient gel of 8M urea. 
Lane 1 (C protein) Lane 2 (IgG) 
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Antigenicity of 150 kD C -protein: 
Antibodies against native 150 kD C-protein were raised in rabbit and 
rats. The titre of antibodies was ascertained by direct binding ELISA wheras 
inhibition ELISA was performed to probe the antigenic specificity of these 
antibodies. 
a) Evaluation of antibody response: 
Direct binding ELISA was used to characterize the immune response 
in rabbit and rats following immunization with 150kD C - protein. 
The serum showed a high titre of greater than 1:12800 (Fig. 7 & 8). 
Pre immune serum served as negative control as it did not show any 
appreciable binding to 150 kD C - protein. 
b) Competition ELISA for the antibodies raised against human heart 
150 kD C - protein: 
The antigenic specificity of the induced antibodies in rabbit and rats 
against human heart 150 kD C - protein was probed by competition 
ELISA. In rabbit, a maximum inhibition of 98.7 percent was obtained 
in immune serum at an inhibition concentration of 10 ng/ml (Fig. 9). 
Whereas the immune serum of rat exhibited a maximum inhibition of 
88.1 percent at inhibitor concentration of 10 |ig/ml (Fig. 10). Fifty per-
cent inhibition was achieved at inhibitor concentration of 0.0016 \xgl 
ml with rabbit serum compared to 0.07 fig/ml with rat serum. 
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Fig. 8 Binding of anti - C protein antibody in rat with C protein. 
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Fig. 9 Inhibition of anti - C protein antibody activity in rabbit. 
Antigen : C protein Competitor : C protein 
0.01 0.1 1.0 
INHIBITOR CONCENTRATION ( >j g / m I ) 
10.0 
Fig. 10 Inhibition of anti - C protein antibody acti\il> in rat by C protein 
Antigen : C protein Competitor : C protein 
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c) Purification of characterization of immune IgG: 
Immune IgG was isolated from serum by Protein - A - Sepharose 4B 
affinity chromatography. The purity of IgG was ascertained by SDS -
PAGE under non - reducing condition (Fig. 11) with the IgG moving 
as a single band. 
Direct binding ELISA of the purified IgG showed strong reactivity 
with the immunogen (Fig. 12). Pre immune IgG as negative control 
showed negligible binding to 150 kD C - protein. 
Antigenic specificities of antibodies induced against human heart 150 
kD C - protein: 
The fine antigenic specificity of antibodies induced against 150 kD C 
- protein was ascertained by competition ELISA. The plates coated with 150 
kD C protein exhibited varying degrees of inhibition against a variety of 
inhibitors. C - protein exhibited maximum inhibition of 98.7 percent at con-
centration of 10 ng/ml when used as an inhibitor. Fifty percent inhibition 
was achieved at a concentration of 0.0016 i^g/ml of inhibition. On ROS 
modification there was a decrease in inhibition of the antibody activity that 
is, 38.7 percent at an inhibitor concentration 10 |Ag/ml. Fifty percent inhi-
bition was not achieved in this case (Fig. 13). Among the three photoadducts 
formed by the interaction of 150 kD C -protein and nDNA, the one formed 
in the presence of OH (ROS DNA-C-protein photoadduct) gave maximum 
inhibition to the tune of 99.2 percent. This was followed by the photoadduct 
formed in the presence of H2O2 (ROS DNA-C-protein adduct) that is 87.8 per-
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Fig. 11 Elution profile of IgG with 0.58% acetic acid and 0.85% Nacl from 
Protein A sepharose CL - 4B column, 
a) DCM IgG b) SLE IgG c) Immune IgG 
Inset shows single band of IgG on 7.5% SDS PAGE 
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Fig. 12 Binding of rabbit immune IgG with C protein 
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Fig. 12 Binding of DCM IgG with C protein 
DCM IgG ( - ) Normal human IgG ( C M D ) 
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cent was observed when the photoadduct was formed only in the presence 
of ultraviolet radiation (UV-B). In all these, the maximum inhibitor concen-
tration was 10 ^g/ml. The same pattern was observed when the concentra-
tion for fifty percent inhibition was taken into account. The photoadduct 
formed in the presence of OH gave fifty percent inhibition at an inhibitor 
concentration of 0.09 \ig/ml followed by the adduct formed in presence of 
H202(3.4 |ag/ml) and photoadduct formed in presence of UV - B irradiation 
(7ng/ml) (Fig. 14). To check the cross reactivity of the induced antibodies, 
various other inhibitors were also used. Out of these histone showed maxi-
mum inhibition of 7.3 percent at 20 [ig/ml which increased to 38.7 percent 
on ROS modification (Fig 15). Poly - D - lysine gave a maximum inhibition 
of 9.9 percent at 20 ixg/ml as compared to Poly L - Glutamate which showed 
inhibition of 30.1 percent. The Poly (L + G) compelx formed after incuba-
tion of Poly - D - lysine and Poly L Glutamate at 37°C for 2 hrs. showed 
maximum inhibition of 25.2 percent. Fifty percent inhibition was not 
achieved in all these cases (Fig. 16). In case of nucleic acids, on ROS 
modification of DNA, extent of inhibition was 15.4 percent at 20 (ig/ml. RNA 
gave an inhibition of 5.2 percent at 20 ng/ml. Fifty percent inhibition was 
not achieved in these two cases (Fig. 17). Percent relative affinity was calcu-
lated for inhibitiors in which fifty percent inhibition was achieved. Out of 
the various inhibitors, photoadduct formed in the presence of OH showed 
highest relative affinity of 1.8 percent followed by photoadduct in pres-
ence of H2 02(0.04 %) and photoadduct in presence of UV - B irradiation 
(0.02%). The results have been summarized in Table 3. 
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Fig. 13 Inhibition of rabbit immune IgG acitivity by native and ROS C pro-
tein. 
Antigen : C protein Competitors : C protein ( O O ) 
ROS C protein ( 0 - ) 
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Fig. 14 Inhibition of rabbit immune IgG activity by nDNA - C protein ad-
ducts 
Antigen : C protein 
Competitors: nDNA - C protein photoadduct 
ROS-DNA - C protein adduct 
ROS-DNA - C protein photoadduct 
(O-O) 
97 
z 
i*J 6 0 
« j 
tLl 
a. 
80 
J_ 
COl 0.1 1.0 10.0 
INHIBITOR CONCENTRATION ( > j g / f D l ) 
100 
Fig. 15 Inhibition of rabbit immune IgG activity by native and ROS Histone 
Antigen : C protein Competitors: Histone ( Q - O ) 
: ROS Histone ( # - ) 
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Fig. 16 Inhibition of rabbit immune IgG acitivity by poly D lysine, poly L. 
glutamate and poly (L+G) complex. 
Antigen : C protein Competitors: Poly D - Lysine (O-O) 
Poly - L Glutamate ( - ) 
Poly (L+G) complex (O-Q) 
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Fig. 17 Inhibition of rabbit immune IgG activity by ROS-DNAand RNA 
Antigen : C protein Competitors: ROS DNA ( # - # ) 
RNA ( O O ) 
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TABLE 3 
ANTIGENIC SPECIFICITY OF ANTI C-PROTEIN ANTIBODIES 
Inhibitors 50% Inhibition Maximum Inhibition % Relative 
(Hg/ml) (at 20 Hg/ml) (%) Affinity 
C-Protein 0.0016 98.7" 100 
ROS C-protein a 38.7'' 
nDNA C-protein 7.0 52.2'' 0.02 
photoadduct 
ROS-DNA-C-protein 3.4 87.8 0.04 
adduct 
ROS-DNA-C-protein 0.09 99.2'' 1.8 
photoadduct 
Histone a 7.3 
ROS Histone a 38.7 
Poly-D-Lysine a 9.9 
Poly-L-Glutamate a 30.1 
Poly (L-G) Complex a 25.2 
ROS DNA a 15.4 
RNA a 5.2 
a = Fifty percent inhibition not achieved, 
b = Maximum inhibition at 10 jig/ml. 
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Binding of total human heart extract (THHE) by DCM autoantibodies: 
Out of the 15 DCM sera tested, most of them showed appreciable bind-
ing with total human heart extract (50 pig/ml). Sera from 9 DCM patients 
gave a titre of more than > 1:6400. Three sera gave a titre of 1:3200 whereas 
two gave a titre of 1:1600 (Fig. 18). 
Recognition of human heart ISO kD C - protein by DCM autoantibodies: 
The sera from DCM patients showed appreciable recognition towards 
gel electroeluted, followed by HPLC purified human heart 150 kD C-pro-
tein. Of the 8 sera tested, 6 sera gave a titre of >r .6400 whereas two sera 
gave a titre of 1:3200 (Fig. 19). The antigenic specificity of autoantibodies 
against 150 kD C-protein was ascertained by competition/inhibition ELISA. 
The 6 sera showing a titre of > 1:6400 were selected for inhibition studies 
(Fig. 20). The degree of inhibition varied from 67.4 percent to 81.2 percent 
at inhibitor concentration of 20 ng/ml. The order of specificity of these DCM 
sera was ascertained by evaluation of concentration for fifty percent inhibi-
tion. The concentration for fifty percent inhibition varied from 0.02 to 2.0 
|ig/ml of inhibitor (Table 4). 
Binding of native DNA with DCM autoantibodies: 
Native ds DNA which is the main trigger for SLE autoantibodies giv-
ing an antibody titer of >1:6400 showed poor recognition with DCM au-
toantibodies. Of the 7 DCM sera tested, one gave a titer of 1:800, followed 
by 1:400 by three sera andtKree sera gave a titre of 1:200 (Fig. 21). 
1 0 2 
DIRECT BINDING ELISA OF THHE WITH DCM 
AUTOANTIBODIES 
6 6 7 8 9 10 11 
Number of serum samples 
Fig. 18 
12 13 14 16 
a 
b 
1 : 1 0 0 
1 :200 
c 
d 
e 
f 
g 
1:400 
1:800 
1: 1600 
1:3200 
1:6400 
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Fig. 19 Inhibition ELISA of DCM autoantibodies with C protein as inhibi-
tor. 
Antigen : C protein Competitor : C protein 
Antibody : Serum 1 ( Q - O ) Serum 4 ( O O ) 
Serum 2 (O-O) Serum 5 0 - 3 ) 
Serums ( - ) Serum 6 ( - ) 
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TABLE 4 
COMPETITION ELISA OF 150 kD CARDIAC C-PROTEIN 
WITH DCM AUTOANTIBODIES 
DCM Sera 50% Inhibition Maximum Inhibition 
(Hg/ml) (at 20 Jlg/ml) (%) 
1 0.5 75.8 
2. 0.03 78.6 
3. 0.24 81.2 
4. 0.02 71.9 
5. 2.0 67.4 
6. 0.6 73.6 
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DIRECT BINDING ELISA OF DCM AUTOANTI-
BODIES WITH 150 KD C-PROTEIN 
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Antigenic specificity of DCM autoantibodies: 
DCM autoantibodies showed variation in percent inhibition with a 
wide spectrum of inhibitors. In all the cases, the coating antigen was hu-
man heart 150 kD C -protein (50 [ig /ml in COj"/ HCO 3- buffer pH 9.6). A 
maximum inhibition of 83.9 percent was obtained at 20 |xg/ml when C pro-
tein was used as inhibitor and fifty percent inhibition was observed at in-
hibit concentration of 0.9 ng/ml. The same on ROS modification showed a 
lesser extent of inhibition which was found to decrease drastically upto 25.8 
percent at 20 jxg/ml. Fifty percent inhibition was not achieved in this cases 
(Fig. 22). The degree of inhibition among the nDNA - C protein photoadducts 
varied in accordance with the agents used in their formation. A maximum 
inhibition to the extent of 90 percent was formed at 20 |xg/ml in case of 
photoadduct formed in presence of OH as compared to inhibition of 88.6 
percent at 20 jxg/ml in case of photoadduct formed in presence of H2 O2. 
Fifty percent inhibition was achieved at 1.0 |ig/ml in latter. The lowest 
amount of inhibition of 41.7 percent was seen in the photoadduct formed 
only in presence of UV - B irradiation (Fig. 23). To check the cross reactivity 
of these antibodies various inhibitors were used. When histone was used as 
an inhibitor, a maximum of 9.2 percent inhibition was achieved at inhibi-
tion concentration of 20 |ig/ml . On ROS modification of the same there 
was an increase of upto 33.9 percent at 20 iig/ml (Fig. 24). Poly - D - Lysine 
and Poly - L - Glutamate gave an inhibition of 6.6 and 40 percent at an 
inhibitor concentration of 20 )ig/ml. The Poly (L + G) complex formed by 
incubation of equimolar concentration of Poly D - Lysine and Poly L -
Glutamate (for 2hrs. at 37°C) gave an inhibition of 34.2 percent at 20 ng/ml 
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Fig. 22 Inhibition of DCM IgG activity by native and ROS C protein 
Competitors: C protein (CKD) ROS C protein ( - ) 
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Fig 2.3 Inhibition of DCM IgG activity by nDN.A - C protein adducts 
Antigen : C protein 
Competitors : nDNA- C protein photoadduct ( # - # ) 
ROS-DNA - C protein adduct ( ( ^ - 3 ) 
ROS-DNA - C protein photoadduct (Q-O) 
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Fig. 24 Inhibition of DCM IgG activity by native and ROS modified histone. 
Antigen : C protein Competitors: Histone ( # - # ) 
ROS Histone ( O O ) 
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Fig. 25 Inhibition of DCM IgG antivity by poly -D-lysine, poly-L-glutamate 
and poly (L+G) complex. 
Antigen C protein 
Competitors: Poly D lysine ((f_o ) 
Poly L Glutamate (O-O ) 
Poly (L+G) complex (^-9) ' 
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Fig. 26 Inhibition nDNA of DCM IgG activity by ROS DNA and RNA. 
Antigen : C-protein Competitors: ROS-DNA(#-# ) 
RNA ( O O ) 
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TABLE 5 
ANTIGENIC SPECIFICITY OF DCM AUTOANTIBODIES 
Inhibitors 50% Inhibition Maximum Inhibition % Relative 
(Hg/ml) (at 20 \lg/m\) (%) Affinity 
C-Protein 0.9 83.9 100 
ROS C-protein a 25.8 
nDNA-C-protein a 41.7 
photoadduct 
ROS-DNA-C-protein 1.2 88.6 75 
adduct 
ROS-DNA-C-protein 1.0 90.0 90 
photoadduct 
Histone a 9.2 
ROS Histone a 33.9 
Poly-D-Lysine a 6.6 
Poly-L-Glutamate a 40.0 
Poly (L-G) Complex a 34.2 
ROS DNA a 15.9 
RNA J .-•> 
a = Fifty percent inhibition not achieved. 
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(Fig. 25). The extent of inhibition was seen to be 15.9 percent on ROS modi-
fication of nDNA. On the other hand, RNA gave an inhibition of 3.3 per-
cent at 20 ^ig/ml (Fig. 26). The percent relative affinity was calculated for 
inhibition in which fifty percent inhibition was achieved. Among the 
photoadducts, the one formed in presence of OH showed elimination in an 
antibody activity as high as to the extent of 90 percent followed by the 
photoadduct formed in presence of H2O2 which showed 75 percent relative 
affinity. In rest of the inhibitors fifty percent inhibition was not achieved. 
Formation of cardiac 150 kD C protein native DNA photoadduct: 
The photocoupling of purified calf thymus native DNA and HPLC 
purified 150 kD C - protein (human heart) was carried out in the presence 
of UV - B irradiation at 254 nm. The photocoupling was allowed to proceed 
at different time intervals of exposure to UV - B radiation (Fig. 27). The 
irradiated samples were extensively dialyzed against PBS, pH 7.4 and 
subjected to ultraviolet spectroscopical analysis. Irradiated DNA showed a 
substantial decrease in absorbance i.e. hypochromism was observed in the 
entire spectral range. Ultraviolet irradiation of C-protein also exhibited 
substantial hypochromism at maxima and minima (Fig. 28) . The native 
DNA - C - protein photoadduct showed relative increase in hypochromicity 
with increase in time of exposure to ultraviolet irradiation . Moreover, there 
was a shift in maxima and minima of the photoadduct as compared to native 
DNA. The maxima showed a shift from 260 nm to 255 nm whereas the shift 
in minima from 230 nm to 235 nm relative to the ultraviolet absorption 
characteristics of native DNA. Also, a sharp decrease in the ratio of 
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Fig. 27 Time course kinetic profile of photoaddition of C protein to native 
DNA. Irradiation time (min) were. a) 10; b) 15 c) 20 and d) 
30. 
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TABLE 6 
UV ABSORPTION CHARACTERSTICS OF FORMATION 
OF nDNA - C PROTEIN PHOTOADDUCTS 
SAMPLES 
native DNA 
(control) 
native DNA 
(Irradiated) 
C protein 
(Control) 
C protein 
(Irradiated) 
nDNA - C protein 
Photoadduct 
Control ( 0 min) 
(10 min) 
(15 min) 
(20min) 
(30min) 
ABSORBANCE 
260 nm 
1.044 
0.901 
0.082 
0.069 
1.071 
0.920 
0.926 
0.946 
0 978 
295nm 
0.091 
0.082 
0.055 
0.052 
0.146 
0.112 
0.116 
0.122 
0.128 
ABSORBANCE RATIO 
260/295 
11.47 
10.99 
1.49 
1.33 
7.34 
8.21 
7.98 
7.75 
7.64 
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260/295 was observed for the photoadduct. This decrease was relative to 
increase in the time of exposure to ultraviolet irradiation. Similarly, native 
DNA and 150 kD C protein individually showed a decrease in 260 / 295 
ratio on ultraviolet irradiation (Table 6 ). 
Format ion of nat ive DNA 150 kD cardiac C - prote in adduct s / 
photoadducts in presence of ROS: 
Electroeluted and electrophoretically pure 150 kD human cardiac C -
protein was covalently crosslinked to purified calf thymus native DNA in 
presence of ROS i.e. U^O^and OH (generated by H^Ojin presence of UV -
B irradiation) (Fig. 29). The samples were extensively dialyzed in PBS, pH 
7.4 and subjected to UV spectroscopical analysis (Fig. 30). A substantial de-
crease in absorbance i.e. hypochromism was observed in the case of 
photoadduct in presence of OH. A sharp decrease in the ratio of 260/295 
was observed in this case. ROS-DNA also exhibited hypchromism but of a 
lower magnitude than the former with reference to native DNA. The nDNA 
- C protein adduct formed in presence of H2O2 exhibited high degree of 
hypochromism with an increase in 260/295 ratio . Furthermore, as evident 
from the (Fig. 30), ROS-C - p io t e in exhibi ted a cer ta in degree of 
hyperchromism at 280 nm with reference to native C - protein. The ultra-
violet spectroscopical characteristics of modified and unmodified samples 
are depicted in table 7. 
De tec t i on of DNA - C - p ro t e in adduc t format ion by a g a r o s e gel 
electrophoresis : 
Agarose gel electrophoresis was carried out to detect the adduction 
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Fig. 29 UV absorption characteristics of: 
native C protein( ) rgxnDNA 
ROS C protein (---- ) ^ ^ROS DNA 
r^ -v ROS-DNA - C protein adduct ( ) 
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TABLE 7 
UV ABSORPTION CHARACTERISTICS OF FORMATION OF 
ADDUCT/PHOTOADDUCT IN PRESENCE OF ROS. 
SAMPLE 
native DNA 
ROS-DNA 
C protein 
ROS-C-protein 
ROS-DNA - C 
adduct 
ROS-DNA - C 
photoadduct 
protein 
protein 
ABSORBANCE 
260nin 
1.944 
1.244 
0.038 
0.066 
1.999 
1.115 
295nni 
0.196 
0.201 
0.023 
0.033 
0.328 
0.140 
ABSORBANCE RATIO 
1 260/295 
9.92 
6.19 
1,65 
2.00 
6.10 
7.96 
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M 3 
Fig. 30 Electrophoretic mobility of samples (1.0 [xg each) after ROS modi-
fication. The samples were run on 1% agarose gel at 30 mA for 2 
hrs. Lane 1 (native DNA) Lane 2 (ROSDNA) Lane 3 (DNA - C pro-
tein + H^O^) Lane 4 (DNA - C protein + H^^^ U V ) 
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Fig. 31 Nuclease SI sensitivitiy of DNA - C protein adducts. DNA - C pro-
tein adducts (1.0 pg) were treated with nuclease SI (20 u/mg of DNA) 
a) nDNA - C protein photoadduct 
b) ROS-DNA - C protein adduct 
c) ROS-DNA - C protein photoadduct 
Lane 1 (control) Lane 2 (treated samples) 
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of DNA to C protein. The adducts were treated with SI nuclease (20 units/ 
Hg adduct) and the digested sample were subjected to electrophoresis . The 
results showed enhanced mobility of SI treated adducts (Fig. 31). This was 
seen in the case of adducts formed in the presence of ROS which include 
HjO^and OH. On the other hand photoadduct formed in the presence of UV 
- B irradiation alone did not show any change in mobility. The untreated 
adducts were used as controls. The results indicated the generation of single 
stranded portions in DNA - C- protein a d d u c t photoadduct formed by H2O2 
and OH as recognised by single strand specific enzyme SI nuclease. 
Kinetic of lysine photoaddition to native DNA: 
The nature of photointeraction between lysine residues of C - protein 
and DNA was also investigated by kinetic study. The irradiated samples 
(10-30 min) were dialyzed against PBS, pH 7.4 and their UV spectra re-
corded. The results showed a constant increase in absorbance at 260 nm 
with the increase in irradiation time. There was a linear increase in percent 
hyperchromicity with the increase in radiant energy (Fig. 32). The number 
of lysine residues in the photoadduct C - protein was determined as a result 
of varying period of UV irradiation (Fig. 33). One lysine molecule of the C-
protein was in the photobound state in between 7.1, 6.3, 5.4 and 3.6 nucle-
otide base pairs of DNA on irradiation for 10, 15, 20 and 30 min. respec-
tively (Fig. 34). The results obtained indicates a progressive increase in the 
photoaddition of lysine molecules (present in C-protein) to DNA with the 
increase in irradiation time. A linear regression plot of hi (Va - Vt) vs. the 
irradiation time 't' gives a straight line which is characteristic of apparent 
first order reaction mechanism (Fig. 35). 
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Fig. 32 Time course pattern of DNA - C protein photoadducts formed by 
UV - B irradiation . The samples (1,0 |ig each) were electrophore-
sed on 1% agarose gel at 30mA for 2 hrs. Lane 1 ( O min.) Lane 2 
(lOmin.) Lane 3 (15 min.) Lane 4 (20 min.) Lane 5 (30 min.) 
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Fig. 33 Standard plot for estimation of lysine by TNBS method. 
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Fig. 34(A) Concentration of photobound lysine at various irradiation times 
in native DNA - C protein photoadduct. 
10 
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Fig. 34 (B) Kinetic profile of photobound lysine residues to native DNA at 
various irradiation t imes. 
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Fig 35 Apparent first order profile of nDNA-C-protein photoadduct forma-
tion at various irradiation times. The values were least square fitted 
and the apparent first orderate constant K was computed from the 
slope. 
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Isolation of DCM and SLE IgG with protein A - sepharose: 
Protein A binds IgG from most mammalian species (Kronvall et al, 
1970; Langone, 1978). Although IgG is the major reactive human 
immunoglobulin, some other types have also demonstrated to bind with 
Protein A. The interaction of Protein A with IgG occurs via Fc portion of 
IgG molecules from many species. 
Protein A sepharose purified IgG's from normal, DCM and SLE sera 
were each found to elute in a single symmetrical peak. The absorbance 
ratio (A^^g/ A^j,) of the peak fraction was found to be 2.5, typical of mam-
malian IgG. The homogeneity of the peak fraction was assessed by its 
single band movement in SDS - PAGE under non reducing conditions 
(Fig. 10) 
Affinity purification of SLE IgG on native DNA - polylysyl sepharose 4B 
column: 
Poly-L - lysine sepharose 4B is an amphoteric derivative of sepharose 
4R which is a group specific absorbent for purification of dsDNA. Poly - L 
- lysine sepharose 4B is prepared by coumpling poly - L - lysine to sepharose 
4B by the cyanogen bromide method. The IgG fractions were collected us-
ing a linear gradient of ionic strength 0.15 - 3.0 M sodium chloride in 0.01 
M phosphate buffer, pH 7.4 (Fig. 36). Affinity purified SLE IgG was found 
to be nearly free from contamination by other classes of immunoglobulins 
as judged by their homogenous movement in SDS PAGE under non reducing 
conditions. 
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Fig. 36 Imraunoaffinity purification of SLE IgG on nDNA-[polylysyl 
sepharose 4B] column 
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Band - shift assay: 
The binding of DCM, SLE and induced 150 kD C - protein antibodies 
with adducts/photoadducts was reiterated by band, shift assay. One micro-
gram each of nDNA - C - protein photoadduct, ROS - nDNA - C protein 
adduct ROS DNA - C - protein photoadduct was incubated with varying 
amounts of DCM, SLE and immune IgG for 2 hrs at 37°C. The immune com-
plex thus formed was kept overnight at 4°C and later electrophoresed on 
1% agarose at 30mA for 2 hrs. in tris acetate EDTA (pH 8 0) . The wells in 
the gel showed increase in the amount of immune complex on increase in 
IgG concentration. A retardation in mobility was also observed indicating 
the strong interaction between the DNA - C - protein adducts and DCM, 
SLE and immune IgG. (Figs. 37, 38, 39). 
Recognition of human cardiac antigens by SLE autoant ibodies: 
The recognitiion of antigens ranging from nucleic acids to myocarditis 
autoantigen (s) by naturally occuring SLE autoantibodies by direct binding 
and competition ELISA irect binding ELISA on plates coated with nucleic 
acid antigens i.e. ds DNA, SS DNA and RNA as well as THHE exhibited 
appreciable reactivity with SLE autoantibodies (Fig. 40). Competit ion 
inhibition ELISA exhibited inhibition in antibody activity with ds DNA, ss 
DNA, RNA (Fig. 41) and THHE (Fig. 42) to a tune of 75.2%, 75%, 10.5% 
and 75% respectively. Fifty percent inhibition varied except in case of RNA 
where it could not be achieved. Protein A-sephorose purified SLE IgG with 
C-protein exhibited inhibition of 79.3% with fifty percent inhibition at 1.8 
Mg/ml (Fig. 43) was employed to further ascertain the specificity. This 
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Fig 37(A) Binding of DCM IgG by DNA - C 
protein photoadduct as analyzed by 
gel retardation assay nDNA - C pro-
tein photoadduct (1 0 ng) was incu-
bated with buffer ( l ane l ) and with 
various concentrat ions of DCM IgG 
(25 (ig, lane 2, 50 (ig. lane 3 and 75 
Mg. lane 4 The complex was electro-
phoresed for 2 hrs on 1% agarose at 
30 mA 
Av '-) ^ 
Fig. 37(B) Binding of SLE IgG by DNA - C pro-
tein photoadduct as analyzed by ge! 
retardation assa\ nDNA - C protein 
photoadduct (1 0 fjg) was incubated 
with buffer ( l ane l ) and with various 
concent ra t ions of SLE IgG (25 |ig. 
lane 2, 50 (jg. lane 3, 75 (ig, lane 4 
The complex was 
electrophoresed for 2 hrs on 1% aga-
rose at 30 iiiA 
1 ^ 3 ^ 5~ 
fig 3 7 ( 0 Binding of anti C" proicin Immune 
IgG b\ nDNA - C protein photoadduct 
as analyzed hy gel retardation assav 
nDNA - C protein photoadduct (1 0 
Mg) was inci'bated with buffer (lane 
1 ) and with \c loiis concentrations of 
anti - (" protein immune IgG (25^ig. 
Lane 2. 50 pg, 1 anc 3, ""5 g Lane 4 
and 150 g. Lane 5) The complex was 
electrophoresed for 2 hrs on l°o aga-
rose at 30 m \ 
1 7. W^ f 
Fig 38(B) Binding of SLE IgG by ROS - D \ A, -
C protein adduct and analyzed b\ gel 
retardation assay ROS-DN A - C pro-
tein adduct (1 0 ng) was incubated 
with buffei (lane 1) and with \ a r ious 
concent ra t ions of SLE IgG (25 pg 
Iane2 50 ng lanel 75 pg lane and 
150 (.ig ) The complex was electro-
phoresed for 2 hrs on l%agaros t at 
iO mA 
'^  3 ;i 1 A ^ 0 
Fig 38(A) Binding of DCM IgG by ROS - 1 ; \ A -
C protein adduct and inalyzed by gel 
retardation assay ROS-DNA - C pro-
tein adduct ( I 0 ng) was incubated 
with buffer ( lane 1) and with \a r ious 
concentrat ions of DCM IgG (25 ng 
lane2, 50 pg lane"? and 1'^ \x% lane 
4) The complex was electrophoresed 
for 2 hrs on 1% agarose at 30 mA 
Fig i8(C) Binding of anti - C protein / Immune 
IgG b \ ROS-DN^ - C protein adduct 
as anaKzed bj gel retardation assay 
ROS-DN^ - C p r o t e i n adduct (1 0 
lag) was incubated with buffer (lane 
1) and with \ar ious concentrations of 
anti - C protein / immune IgG (25 iig 
lane2' '50Lig lane3''75Mg lane 4 150 
Hg lane 5) The complex was electro-
phoresed for 2 hr on 1% agarose at 
30 mA 
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Fig 39(A)Binding of DCM IgG by ROS DNA -
C protein phoioadduct as analyzed by 
gel retardation assay ROS DNA - C 
protein photoadduct (1 Ong) was in-
cubated with buffer (lane 1) and with 
various concentrations of DCM IgG 
(25 Jig, lane2, 50 ^^g lane 3, 75 ng, 
lane 4 and 150 |ig, l aneS) The 
complexed was electrophoresed for 2 
hrs on 1% agarose at 30 mA 
i ^ 3 ^ 5' 
"w' Wp, jfKt^.m^-^^ 
Fig 39(B) Binding of SLE IgG by ROS DNA - C 
protein photoadduct as analyzed by 
gel retardation assay ROS DNA - C 
prote in photoadduct (1 O^g) was in-
cubated with buffer (lane 1) and with 
various concentrations of SLE IgG (25 
Hg lane2 50 )ig, lane 3, 75 ng, lane 
4 and 150 fig lane'>) The complexed 
was elec'.rophorestd for 2 hrs on 1% 
agarose at '^ O mA 
1 ^ 5 ^ r 
Fig 39(C) Binding of anti - C protein / immune 
IgG by ROS - DNA - C p r o t e i n 
photoadduct as analyzed b> gel retar-
dation assa\ ROS DNA - C protein 
photoadduct (1 0 \ig) was incubated 
with buffer (lane 1) and with \ a r ious 
concentration^, of anti - ( protein / 
immune IgG (25 g lane2 50g lane3 
75 g lane 4 and 150 g lane 5) The 
complex was electrophoresed for 2 hr 
on P/o agarose at 30 mA 
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Fig. 40 Binding of SLE auto antibodies with ds DNA, ssDNA, RNA and THHE 
dsDNA iA-k) ss DNA ( S - ^ ) 
RNA ( A ^ ) THHE ( © ^ ) 
NHS {O-O} 
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Fig. 41 Inhibition ELISA of SLE autoantibodies on plates coated with na-
tive DNA 
Competi tors: native DNA(O-O) ss DNA (A- t^) 
RNA ( § . # ) 
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Fig. 42 Inhibition ELISA of SLE autoantibodies on plates coated with ds 
DNA 
Competitor : THHE ( • - • ) 
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Fig. 43 Inhibition ELISA of protein A sepharose isolated SLE IgG on plates 
coated with ds DNA 
Competitor : THHE ( • - • ) 
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Fig. 44 Inhibition ELISA of i 
Competitor : C protein 
immunoaffinity purified SLE IgG 
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revealed inhibition of 76% and fifty percent inhibition was achieved at 1.5 
^g/ml (Fig. 44). 
Probing mitochondrial DNA damage in DCM patients: 
The sera from DCM patients showed preferentially higher binding with 
native mitochondrial DNA (mt DNA) as compared to its ROS modified 
conformer (Fig. 45). The specifity was ascertained by inhibition ELISA. The 
six DCM sera tested showed inhibition in the antibody activity, ranging from 
64.5 percent to 73.1 percent in case of native mt DNA (Fig. 46) as compared 
to inhibition varying from 54.6 percent to 63.8 percent in case of ROS mt 
DNA (Fig. 47) at maximum inhibitor concentration of 20 pig/ml. The range of 
inhibitor concentration for fifty percent inhibito varied from 0.15 to 4.0 
jxg/ml in native mt DNA. In ROS mt DNA, fifty percent inhibition was 
achieved in the range of 2.0 jig/ml to 10.0 [ig/ml in the six tested DCM 
sera. The results have been summarized in Table 9. 
Glucose, cholesterol, uric acid estimation and evaluation of CRP and RF 
content in patients with dilated cardiomyopathy (DCM): 
Elevated levels of glucose that is 146.1, 115.3 and 115 mg/dl were 
found in 3 of 15 DCM patients under taken in this study (Fig. 48). Amongst 
them only one showed higher level of serum cholesterol that is 248 mg/dl 
(Fig. 49). An increase in uric acid content in serum was found in 7 of the 9 
female patients, in the range of 4.5 to 24.9 mg/dl. The males showed a varia-
tion from 4.3 to 11.2 mg/dl (Fig. 50). The C reactive protein (CRP) latex 
agglutination test revealed positive agglutination (>6mg/dl) in 9 out of 15 
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DIRECT BINDING ELISA OF DCM AUTO ANTI-
BODIES WITH NATIVE AND ROS mt DNA 
3 4 6 6 
Number of serum samples 
[HID Native mt DNA ROS mt DNA 
Fig. 46 
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Fig. 46 Inhibition ELISA of DCM auto antibodies with native mt DNA as 
inhibitor 
Competitor: native mt DNA 
(O-O ) Serum 4 ( o - o ) 
( o - O ) Serum 5 ( O-O) 
( ©-€)) Serum 6 ( • - • ) 
Antigen : native mt DNA 
Antibody : Serum 1 
Serum 2 
Serum 3 
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Fig. 47 Inhibition ELISA of DCM auto antibodies with ROS mt DNA as 
inhibitor. 
Antigen : ROS mt DNA 
Antibody : Serum 1 
Serum 2 
Serum 3 
Competitor : 
(a—O) Serum 4 
{9—0) Serum 5 
(•—•) Serum 6 
ROS mt DNA 
{o-o) 
(•-») 
( — ) 
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TABLE 8 
COMPETITION ELISA OF MITOCHONDRIAL DNA (mtDNA) WITH 
DCM AUTOANTIBODIES 
DCM Sera 
50% In 
{\lg/m\) 
1 1 6 
2 1 1 
3 1 0 
4 0 15 
5 4 0 
6 2 4 
Antigen-
Inhibitoi 
hibition 
mt DNA 
r-mt DNA 
Maximum 
Inhibition 
(at 20 ng/ml)% 
67 6 
64 5 
73 1 
64 9 
65 6 
65 2 
50% 
Antigen -
In 
In 
(^ig/ml) 
3 0 
2 4 
2 2 
2 0 
100 
5 0 
ihibitor 
hibition 
ROS mt DNA 
- ROS mt DNA 
Maximum 
Inhibition 
(at 20 p,g/ml)% 
63 8 
61 0 
63 2 
58 2 
54 6 
56 8 
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GLUCOSE LEVELS IN SERA OF PATIENTS WITH 
DILATED CARDIOMYOPATHY 
160 Y[ 
E 
tn 
O 
O 
:s 
1—1 
F i g . 48 
4 6 6 7 8 9 10 11 12 13 14 16 
Number of serum samples 
Normal range-. 70-100 mg/dl 
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TOTAL SERUM CHOLESTEROL LEVELS IN 
PATIENTS WITH DILATED CARDIOMYOPATHY 
S 
c 
<u 
•p 
c 
o 
o 
o 
« 
r-l 
o 
x: 
u 
1 2 3 4 6 6 7 8 9 10 11 12 13 14 16 
Number of serum samples 
F i g . 49 Normal range: 130.0-220.0 mg/dl 
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LEVELS OF URIC ACID IN SERA OF PATIENTS 
WITH DILATED CARDIOMYOPATHY 
s 
T3 
•H 
u 
u 
e 
D 
0) 
Fig . 50 
5 6 7 8 9 10 11 12 13 14 
Number of serum samples 
Normal range :-
Males: 3.4 - 7.0mg/dl 
Females: 2.4 - 6.7 mg / dl 
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C - REACTIVE PROTEIN (CRP) LEVELS IN 
SERA OF PATIENTS WITH DILATED CARDIO-
MYOPATHY 
•p 
c 
Q) 
^J 
C 
O 
o 
a, 
200 
160 
100 
60 
T 1 r 
6 6 7 8 9 10 11 12 13 14 16 
Number of serum samples 
F i g . 51 Normal CRP content < 6mg/L 
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patients in qualitative estimation. Semiquantitative analysis of the positive 
samples showed variations in CRP contents from 12 mg/dl in 4 sera, 24 mg/ 
1 in 2 sera to 48 , 96 and 192 mg/1 in one serum each of DCM patients 
(Fig. 51). Qualitative analysis of Rheumatoid factor (RF) by RF latex agglu-
tination test did not show any agglutination in any of the tested DCM sera. 
B xscuBsion 
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A utoimmune diseases are characterized by the presence of circu-
lating autoantibodies which are not necessarily pathogenic but represent 
markers of immune mediated injury (Rosa, R and Bona, C, 1991). Autoim-
mune diseases result due to humoral and / or cellular immunological reac-
tions against the self components of an individual. The triggering mecha-
nisms of autoimmune reaction have not yet been completely understood. 
Shoenfeld and Isenberg (1989) described the Avide spectrum of autoimmune 
diseases as mosaic of autoimmunity with many factors leading to various 
diseases. 
Dilated cardiomyopathy (DCM) is a chronic heart muscle disease of 
unknown etiology characterized by dilatation and contractile dysfunction 
of left and / or the right ventricle. In man, myocarditis is known to be the 
precursor of DCM in many cases, although clinical and histological diag-
nosis remain problematic. Since in DCM, the only affected organ is heart, it 
fits into the criteria of organ specific autoimmune disease. Autoimmune 
features in patients with DCM include familial aggregation (Keeling et al. , 
1995), a weak association with HLA DR4 (Carlq uist et al., 1991) and im-
munoglobulin genes ( Martinetti et al., 1992), abnormal expression of HLA 
class II on cardiac endothelium (Caforio et al., 1990), and increased levels 
of circulating cytokines (Limas et al., 1995). 
Several groups have found cardiac antibodies to various antigens in 
DCM (Caforio et al . , 1992; Schultheiss et al., 1990; Limas et al., 1995). 
Multiplicity of parallel autoimmune reactions directed towards a single or-
gan may be due to spread sensitization (Bach, 1995). Among the various 
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cardiac antigens, 150 kD C protein has been found to be a potent antigen 
causing autoimmune myocarditis in experimental animals. C protein plays 
an important role in contractile activity. It is one of the major constituent 
proteins which are essential to compete with natural antigens at MHC - an-
tigen bindings site (Demotz et al., 1990; Harding and Unanue, 1990). More-
over C protein is an intracellular member of immunoglubin superfamily 
(Einheber and Fischman, 1990). Due to identical molecular weights IgG, 
and C protein gave a similar pattern on 7.5% SDS - PAGE. Urea denatur-
ation studies also showed more or less similar patterns in Urea - SDS -
PAGE. When SDS -PAGE was performed with a urea gradient (1-10 M urea) 
as well as acrylamide gradient (5-20%), both IgG and C protein were dena-
tured to give two prominent bands each. This further gives an insight into 
this theory. The HLA binding motifs are located in the variable domain and 
not the constant IgG like domain (Rudensky et al., 1992; Baum et al., 1993). 
The thermal behaviour of 150 kD C - protein and human IgG as con-
trol displaying Tm values of unfolding at around 79.5°C is typical of a highly 
stable dimeric protein molecule. The highly stable conformational state of 
150 kD C - protein was evident from the observation that only 4.4% had 
undergone thermal unfolding till 75°C. Thus our observation reveals for 
the tremendous structural stability of the 150 kD C - protein auto antigen. 
Additional evidence for the structural changes in native 150 kD C-
protein as a result of thermal energy supplementation was revealed by ana-
lyzing the data and computation of thermodynamic parameters (Table 1 & 
2). The thermodynamical data speculate the tremendous structural stability 
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exhibited by 150 kD C - protein. Disruption of the hydrophobic and ionic 
interaction as well as disulfide bonds in the 150 kD C - protein which 
ultimately resulted in unfolding was inferred from the shift in the scales of 
the AGJJ values. The negative AG^ values above 79°C suggests the transi-
tions of completely folded 150kD C - protein to the unfolded state. Further-
more, in comparison to the already established thermodynamic behaviour of 
native DNA, our results are indicative for the 150 kD C - protein to be topo-
logically less constrained than nucleic acids. This comparative analysis has 
been pointed out due to the important factor of DNA acting as auto antigen 
in SLE whereas 150 kD - C-protein acting as autoantigen in DCM / 
myocarditis and that as per our observations, the 150 kD C - protein which 
acts as autoantigen in myocarditis was found to be equally reactive with 
naturally occuring SLE autoantibodies. 
Photochemical reaction have been found to produce DNA - protein 
crosslinks in biological systems. Proteins and nucleic acids are colourless 
macromolecules which absorb in the UV range of spectrum. These two 
biomolecules coexist in vivo and their interaction results in biological dam-
age in organisms. The crosslinking between DNA and protein has been found 
to be covalent in nature. (Oleinick et al., 1986). In this study , we have 
formed photoadducts between native DNA and C - protein in UV light (254 
nm). Time course kinetics revealed that the formation of photoadduct in-
creased with increase in duration of exposure to UV irradiation. This was 
further reiterated by the amount of total protein bound to DNA. The protein 
content increased remarkably with the increase in period of exposure. The 
amount of lysine residues present in C-protein were estimated to assess their 
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binding to native DNA. Time course kinetic study indicates that the forma-
tion of photoadduct obeys apparent first order reaction. 
Oxygen free radicals (OFR's) occupy a prime position in the world of 
free radical biochemistry . The prima donna in this category are oxygen 
itself, superoxide, hydrogen peroxide, transition metal ions and hydroxyl 
radicals, where the first four interact in many ways to produce the last 
(Halliwell and Gutteridge, 1990). Exogenous sources like toxic foreign com-
pounds and ionizing radiations are known to increase the production of free 
radicals. There are several sites for generation of reactive oxygen species 
(ROS) in cells, but the main source is the autooxidation of reduced compo-
nents of mitochondrial transport chain (Haiku et al., 1993). 
Reactive oxygen species produce DNA - protein crosslinks in biologi-
cal systems. Here we have taken two entities, hydrogen peroxide (H^ 
O^) and hydroxyl radical (OH) to produce crosslinks and photoadduct for-
mation between native DNA and C - protein. Among the two, hydroxyl radi-
cal (OH) appeared to be a better agent to induce DNA - C- protein crosslinks. 
The formation of photoadduct in the above cases causes single strand breaks 
in DNA as revealed by nuclease SI sensitivity assay. On the contrary, the 
control and treated samples of nDNA C-protein photoadduct showed the 
same pattern. It signifies that in the photoadduct, interaction may have taken 
place via lysine residues. The other aminoacids in the protein can also un-
dergo photointeraction to form protein-protein photoadduct. Thus, crosslinks 
are again formed between nDNA C-protein and C-protein C-prote in 
photoadduct which is responsible for such a pattern. 
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The recognition between nucleic acid and proteins is of great signifi-
cance as it triggers most important steps of nucleic acid metabolism. This 
recognition involves electrostatic interactions between phosphate groups and 
positively charged groups in protein. Later more specific interactions be-
tween nucleic acid bases (or other structural elements) and amino acid side 
chains in proteins take place. A closer look reveals the possible recognition 
of secondary structure of nucleic acids by proteins, either way recognition 
is dependant of nucleotide sequence (Duguet, 1981). 
A different chemistry arises when protein and DNA are irradiated to-
gether or separately. Since DNA and protein are in intimate contact with 
each other in vivo, it is suggested that photochemical interaction of DNA 
and protein would play a significant role in the inactivation of UV irradi-
ated cells under certain conditions. 
The photoadducts formed showed appreciable reco. gnition with DCM, 
SLE and immune sera. The reactivity of DCM and immune sera was maxi-
mum with photoadduct formed by hydroxyl radical (OH) followed by the 
one formed only in the presence of UVB irradiation showed least reactivity 
as shown by band shift assay and completion ELISA studies. This indicates 
the effectiveness of hydroxyl radical(-OH) to generate DNA protein crosslinks 
which produce pathological changes. 
The sera of patients with dilated cardiomyopathy (DCM) showed a 
typical picture in the biochemical investigations . Quantitative determina-
tion of serum cholesterol gave normal values except for one patient. The 
determination of serum cholesterol is considered to be significant mostly 
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in coronary artery diseases, hyperlipoproteinemas, hypothyroidism, 
nephrosis, diabetes mellitus, and various liver diseases, and has very little 
role to play in dilated cardiomyopathy (DCM). Similarly patients with DCM 
rarely show an increase of serum glucose. Only two of the total fifteen cases 
showed a moderate increase in glucose levels. The moderate rise is associ-
ated with infectious diseases, intracranial diseases and haemorrhage. There 
was a significant increase in uric acid levels in serum. Serum or plasma 
uric acid determination has an important diagnostic values in gout and kid-
ney failure. It is also increased in acute stages of infectious diseases, se-
vere uremia, toxemia of pregnancy and leukemia. DCM is a end stage car-
diac disorder in which there is active degeneration of cardiac tissue leading 
to heart failure. This chronic inflammatory process may be responsible for 
increase in uric acid levels in DCM patients. 
A significant rise was observed in the C - reactive protein (CRP) lev-
els in sera of DCM patients. A majority of patients gave a high titre on semi 
- quantitative determination of CRP in serum. CRP an acute phase reactant 
is considered to be the most sensitive marker in the acute phase and there-
fore, a universal early indicator for inflammatory, necrotic and neoplastic 
diseases. CRP is a non - glycosylated cyclic pentamer which increases in 
concentration in a fixed and phased sequence during inflammation and / or 
active tissue infections. It is important in protection against development 
of autoimmunity. It acts by clearing cell debris autoantigens recognised by 
auto antibodies. The rise in CRP levels in DCM patients can be attributed 
to this factor. Rheumatoid factor (RF) was absent in all the sera of DCM 
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patients. RF are credible markers in inflammatory diseases of the joints . 
Hence their absence rules out the possibility of any such factor in DCM. 
Autoantibodies found in patients with dilated cardiomyopathy (DCM) 
exhibited remarkable binding with the HPLC purified 150kD human C-pro-
tein as is evident from competition inhibition ELISA results. Nearly all the 
sera of patients with DCM showed inhibition in the antibody activity by 
150 kD C-protein in the range of 64 .7% to 82.1%. Furthermore, an appre-
ciable number of DCM sera exhibited inhibition in their antibody activity 
by a very low magnitude of inhibitor concentration, which in turn, is fur-
ther substantiative/or indicative for the remarkably high specificity of the 
DCM autoantibodies towards 150kD C-protein. However, the binding to-
wards 150kD C-protein was of higher magnitude with the induced anti 150 
kD C-protein antibodies in comparison to the binding with DCM autoanti-
bodies. The binding results are suggestive for the major involvement of 
150kD C-protein as autoantigen in autoimmune DCM/myocarditis. 
It is to be pointed out that native DNA was found to be of low reactiv-
ity with all the sera of patients with DCM. But interestingly, mitochondrial 
DNA (mt DNA) on the other hand, exhibited appreciable binding with DCM 
autoantibodies, although the magnitude of binding was lower than with 
150kD C-protein. Moreover, surprisingly, modification of mt DNA with ROS 
showed decrease in binding with DCM autoantibodies, whereas conversely, 
nDNA which was unreactive towards DCM autoantibodies, showed a bind-
ing of low magnitude when modified with ROS. The results are suggestive 
for the probable presence of conformational epitopes on mtDNA and to a 
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lower extent on ROS DNA which are somewhat similar to the ones present 
on 150 kD C-protein. 
The highly immunogenic nature of native 150kD C-protein was evi-
dent from the competition results, where around 98 percent of the antibody 
activity was inhibited by the immunogen. However, when native 150kD C-
protein was ROS modified, the antibody binding was lost to the extent of 
more than fifty percent. The results suggest for the damage or loss of sig-
nificant number of immunodominant epitopes on 150kD C-protein upon ROS 
modification. 
Although the induced anti-150kD C-protein antibodies were unreactive 
with native DNA, a low magnitude of binding was observed when nDNA 
was photoadducted with C-protein, whereas, surprisingly, ROS-DNA-C-Pro-
tein photoadduct exhibited a high degree of binding which was even higher 
than the binding observed with the immunogen i.e. 150kD C-protein. This 
could be attributed to the cumulative binding effect of immunogenic epitopes 
on C-protein as well as somewhat similar epitopes to the immunogen on the 
ROS modified DNA and hence when both ROS-DNA and C-protein were 
photoadducted, a higher binding was observed. The results suggest that prob-
ably apart from 150kD C-protein, the photoadducted ROS-DNA C-protein 
complex could also act as an alternate autoantigen for myocarditis/DCM. 
The above possibility could not be ruled out because of the fact that reac-
tive oxygen species (ROS) are formed in vivo which modifies the nucleic 
acid macromolecule and that the possibililty of photoconjugation of ROS-
DNA with C-protein exists. Thus, our findings could possibly throw some 
light on the pathogenesis and etiology of autoimmune myocarditis/DCM. 
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The binding of induced anti-C-protein antibodies with histones, ROS-
histone, poly-D-lysine, poly-L-glutamate and poly (lysine-glutamate) com-
plex was of low magnitudes thereby suggesting for the presence of a minor 
sub-population of epitopes responding to the anti-C-protein antibodies. Simi-
lar binding results were also observed with DCM autoantibodies against C-
protein, ROS C-protein ROS-DNA, ROS-DNA photoadducted to C-protein, 
ROS-histone, histones, poly-D-lysine, poly-D-glutamate and poly (L+G) 
complex respectively. The similarity in binding results further substanti-
ates the above argument. 
Apart from the above the systematic probe to see the correlation be-
tween myocarditis autoantigen (C-protein) and autoimmune SLE autoanti-
bodies gave encouraging results. 
Systemic lupus erythematosus (SLE) is a multisystem prototype au-
toimmune disease (StoUar, 1981) characterized by circulating autoantibod-
ies that bind to cellular antigens of self and exogenous origin. Although the 
correlation of SLE with immune system is well documented, neither the 
origin of these autoantibodies nor the etiology of the disease is known. Re-
cent studies point out that native DNA might actually be a cross reactive 
antigen whereas some other structures like modified nucleic acids (Alan et 
al., 1993; Ara and AH; 1993; Ara and Ali, 1992), polypeptides (Arif et al., 
1994) and phospholipids (Smeenk et al., 1987), etc. stimulate the antibody 
response. Moreover, the polyspecificity of autoantibodies with a variety of 
heteroantigens might be the result of immune response to substance (s) other 
than native DNA and interplay of some environmental factors. 
158 
In the present study attempts were also made -to probe the possible 
involvement of 150 kD C - protein isolated from human heart which is known 
as potential autoantigen in myocarditis and DCM in humans , in autoimmune 
SLE. The protein is known to have similar domain as to those of IgG and 
has been implicated in the induction of autoantibodies in patients with SLE. 
The 150 kD C- protein, which is a component of thick filament of skeletal 
and cardiac muscles, plays an important role in the contractile activity. 
Assays of anti - DNA and anti - human heart antigens in the sera of patients 
with SLE and DCM respectively were carried out by employing direct 
binding ELISA whereas specificity determination was accomplished by 
competition ELISA. The antigen binding characteris t ics of anti - DNA 
autoantibodies towards native and modified nucleic acids were in accordance 
with earlier findings (Losman et al., 1993). 
The most striking finding of the present study is the appreciable 
recognition of THHE as well as 150 kD C - protein (human heart) by SLE 
autoantibodies. As revealed by competition inhibit ion studies, the SLE 
autoantibodies expressing specificity towards dsDNA, ssDNA, DNA-lysine 
photoadduct and Br - DNA also showed almost similar recognition of human 
heart proteinic antigen (s) . Interestingly, as evident from the binding results 
the human heart extract antigens reactive with the DCM autoantibodies 
showed strong recognition of SLE anti-DNA autoantibodies whereas on the 
contrary DNA was found to be less reactive with DCM autoantibodies. This 
is suggestive for the possible involvement of a common or somewhat similar 
trigger/epitope (s) for immune response in autoimmune myocarditis/DCM 
and autoimmune SLE, although such inferences could not lead to confirmity 
at such a preliminary stage of investigation. Moreover, the high binding 
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Specificity of immunoaffinity purified anti - DNA antibodies to 150 kD C -
protein from human heart is strongly suggestive for the presence of 
immunodominant epitopes on 150 kD C- protein for SLE anti - DNA anti-
body binding. The binding results are indicative for the presence of unique 
conformational epitopes on the 150 kD C - protein whose domains are some-
what similar to IgG. It is to be pointed out that recently nucleosome spe-
cific antibodies have been indicated in lupus prone mice. The monoclonal 
antibody was found to react with nucleosome core particle but not histone-
histone and histone-DNA complexes. The core particles having ordered as-
sociation of histones and DNA were found to express a unique conforma-
tional autotpitope (s). Only the pathogenic T - helper cells of lupus prone 
mice responded to nucelosomal antigens and their stimulation was specific 
(Chandra et al., 1993). Therefore, it appears that pathogenic anti - DNA 
autoantibodies are generated through some conformational epitope (s) of 
nucleic acids or proteins / polypeptides. 
Thus, in view of the above argument, it appears from our data that 
150 kD C-protein having domains similar to those of IgG and being involved 
in the induction of autoimmune myocarditis may provide some unique con-
formational epitopes which could possibly act as an alternate autoantigen 
or trigger in the production of anti-DNA autoantibodies in SLE. Our pre-
liminary investigation is supportive for the above argument. The mecha-
nism or the role of myocarditis inducing 150 kD human heart C-protein in 
the stimulation of immune system for the production of antibodies in SLE 
remains to be ascertained. 
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In conclusion, it would be inferred from this study.that: 
(1) 150kD C-protein is having somewhat similar domains to human IgG 
as indicated by urea SDS-PAGE. 
(2) 150kD C-protein was thermodynamically more stable than human IgG 
although both of them had somewhat similar domains. 
(3) The C-protein is a potent immunogen inducing hightiter polyclonal 
antibodies with major reactivity towards HPLC purified immunogen. 
(4) Nearly all the DCM sera tested exhibited elevated C-reactive protein 
(CRP) and uric acid levels and that all of them showed remarkable 
recognition towards electroeluted.followed by HPLC purified 150kD 
C-protein. 
(5) The kinetics of formation of DNA-C-protein photoadduct at various 
irradiation time obeyed the apparent first order reaction. 
(6) Out of the various adducts/photoadducts formed by crosslinking na-
tive DNA with C-protein, the one formed in the presence of'OH (ROS 
-DNA-C-protein photoadduct) showed highest reactivity with DCM, 
SLE and immune IgG. 
(7) Nearly all the DCM sera tested, showed preferentially higher binding 
with native mitochondrial DNA than its ROS modified conformer. 
(8) The most striking finding is the appreciable recognition of THHE as 
well as 150 kD cardiac C-protein by immunoaffinity purified anti-DNA 
SLE autoantibodies. 
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